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ABSTRACT
CAUSAL EFFECT ESTIMATION UNDER LINEAR AND LOG-LINEAR
STRUCTURAL NESTED MEAN MODELS IN THE PRESENCE OF
UNMEASURED CONFOUNDING
Chia-Hao Wang
Thomas R. Ten Have
In randomized clinical trials where the effects of post-randomization factors are of
interest, the standard regression analyses are biased due to unmeasured confounding.
Causal methods such as the instrumental variables (IV; Angrist et al., 1996) and Gestimation procedures under structural nested mean models (SNMMs; Robins, 1994,
1997) allow one to make valid inference even if unmeasured confounding is present.
Two commonly used IV approaches, namely the two-stage predictor substitution
(2SPS) and two-stage residual inclusion (2SRI), are typically applied in analysis assuming the exclusion restriction to adjust for confounding. However, the exclusion
restriction may be violated in clinical applications especially when the mechanism of
treatment is assessed under mediation analyses. Accordingly, we focus on estimating the direct effect of the randomized treatment adjusting for a post-randomization
mediator (mediation analysis). In the first chapter, we extend the two IV approaches
to estimate the direct effect, and evaluate the corresponding theoretical properties
under the linear SNMM. Under certain assumptions, we have shown that the 2SPS
iv

and 2SRI approaches are equivalent to the linear SNMM. In the second chapter,
we further extend and investigate the validity of these IV methods for estimation
under a log-linear SNMM. The results show that the IV estimators are biased under
the log-linear SNMM in the presence of unmeasured confounding. Therefore, in the
third chapter we consider the G-estimation approach as an alternative solution to
remove bias under the log-linear SNMM. The G-estimation method was previously
developed under either the exclusion restriction assumption or the sequential ignorability assumption. We present a general framework where these two assumptions
are relaxed. In contrast to the IV log-linear regression methods, we have shown that
the proposed G-estimators are unbiased in the presence of unmeasured confounding.
Finally, we illustrate all methods in a lung cancer randomized trial for mediation
analysis where the sequential ignorability assumption is violated. The results are
discussed and compared to those from the standard regression approach.
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Chapter 1
Introduction
In many clinical or epidemiologic studies, investigators are interested in comparing a treatment group and a control group to make inference on the effect of
treatment. A common problem for estimating the effect of interest is the potential
bias resulting from unmeasured confounding. Traditional methods such as matching, stratification, and multiple regression analysis have been used to adjust for
confounding. However, since we cannot possibly identify and adjust for all the confounding variables, complication arises and these methods can still produce biased
results. Knowing that inference for treatment effect using the traditional approaches
is often complicated by the presence of unmeasured confounding, the potential outcome framework (Neyman, 1923; Rubin, 1974) and the corresponding causal inference methods, such as the instrumental variables (IV; Angrist et al., 1996; Hernán
and Robins, 2006; Johnston et al, 2008) and the structural nested mean model
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(SNMM)/G-estimation (Robins, 1994, 1997; Robins et al., 1999), have been developed to provide ideal frameworks for dealing with confounding in clinical studies.

1.1

Overview of the potential outcome framework

To discuss the causal models, we first distinguish causality from association to
introduce the concepts of causal effects. The associational inference is more descriptive of the characteristics of a subject at a particular time. In comparison, causal
inference is interested in estimating the effect of a cause on the outcome. Variables
considered in causal studies are divided into two classes: pre-exposure and postexposure to a cause. The outcome becomes a post-exposure variable that measures
the effect of the cause. In causal inference, the effect of a cause is always relative to
another cause and the interest is to compare the difference in effect on the outcome
if the same subject is exposed and not exposed to a cause. This brings the concept of
potential outcomes and it is critical to assume that each subject can be potentially
exposable to any one of the causes. In the setting of controlled clinical trials, causes
can be different types of treatments. It is important to distinguish the potential
outcomes from the observed outcome. In reality, only one of the potential outcomes
will be the observed outcome given the observed treatment. Since it is impossible
to observe both outcomes for the same subject, the effect of treatment on a subject
is not measurable. The goal in causal inference is to express the non-observable potential outcomes in terms of the observed response variable. To do this requires two
2

important assumptions in causal modeling: the independence/randomization and
stable unit treatment value (SUTVA; Rubin, 1986; Angrist et al., 1996) assumptions, which will be discussed in details in later chapters. Under these assumptions,
we can characterize the average causal effect of treatment by estimating the difference of the expected outcome between treatment and control groups that can be
observed over a population of subjects. Holland (1986) refers this framework via potential outcomes as ”Rubin’s Model”, which provides a basis to do causal inference.

1.2

IV approaches within the context of causal
models

IV have long been used by economists to specify causal links between variables in
the context of two-stage structural equation models (SEM; e.g, Goldberger, 1972).
Conventionally, IV in the two-stage SEM are explicitly included in the first-stage
model and excluded from the second-stage model, and therefore are only correlated
with the second-stage outcome through their effects on the first-stage outcome (endogenous variable).
To bridge the gap between statisticians and economists, Angrist et al. (1996) proposed a modification of the IV methods using the Rubin’s Causal Model to estimate
the effect of non-compliance on outcome in a randomized trial. More specifically,
they consider the following context. Subjects in a trial have access to both active

3

and control treatments. They have different preferences and can decide which treatment to take. In such cases, subjects are classified as one of four types: compliers,
defiers, never-takers and always-takers. Compliers are those subjects who will adopt
whatever treatment they are assigned to, defiers are those subjects who will adopt
the opposite treatment to their assignment. Never-takers are subjects who always
take the control treatment regardless of what they are assigned to. Always-takers are
those who always take the active treatment regardless of their assignments. Specifically, if we observe that a subject is assigned to active treatment and complies, he
can be a complier or an always-taker. If we observe that a subject is assigned to
control treatment and complies, he can be a complier or a never-taker. Therefore, we
observe compliance status only for the assigned treatment, and the full compliance
status is not completely observed.
To identify the compliance status and causal effects, a number of assumptions are
made. One of the major assumptions is the exclusion restriction, which says that
treatment assignment is unrelated to potential outcomes once treatment received
is taken into account. By the exclusion restriction assumption, always-takers and
never-takers have zero causal treatment effect on the outcome. Along with other
assumptions, Angrist et al. (1996) have shown that the IV estimate is the Local
Average Treatment Effect (LATE). This effect is also known as the Complier Average Causal Effect (CACE, Little and Rubin, 2000), which is the average causal
effect among compliers. The CACE is valid because it is the causal effects for the
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”true” compliers who always take the assigned treatment rather than the ”observed”
compliers. We can express the CACE as the estimated intent-to-treat (ITT) effect
divided by the difference in proportions for subjects who take the active treatment
in both groups. Under perfect compliance, the IV approach is the ITT analysis.
These concepts have subsequently been introduced to clinical and epidemiologic
studies (Bellamy et al., 2007; Greenland, 2000). The approaches are commonly applied to make valid causal inference in observational studies (e.g. Stukel et al., 2007;
Hogan and Lancaster, 2004) or in clinical controlled trials with non-compliance (e.g.
Dunn et al, 2003) where unmeasured confounders are likely to be present. The advantage of the IV approaches is that they consistently estimate additive causal effects
under the specified assumptions regardless of whether we measured the covariates
normally required to adjust for the unmeasured confounders.
Two specific IV approaches, known as the two-stage predictor substitution (2SPS)
and two-stage residual inclusion (2SRI) analyses, have been performed for linear and
non-linear models (Mullahy, 1997; Terza et. al., 2008; Johnston et. al., 2008; Dunn
and Bentall, 2007). Both approaches require two steps and have the same first-stage
procedures. In the first stage, we regress the endogenous variable on selected instrumental variables to obtain the predicted value of the endogenous variable. In order
to achieve identifiability, the number of instrumental variables should not be less
than the number of causal parameters. In many cases, the randomization variable
and its interactions with baseline covariates that are strong predictors of the endoge-
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nous variable are selected as instrumental variables. In the second-stage regression,
we replace the endogenous variable by its predicted value for the 2SPS approach. In
contrast, instead of replacing the endogenous variable in the second-stage estimation,
the 2SRI approach includes the residual of the endogenous variable as an additional
regressor. When analyzing binary data assuming the exclusion restriction, the 2SRI
IV approach has been shown to be unbiased in contrast to the 2SPS approach, with
respect to the causal effect of receiving treatment conditional on the unobserved confounder when there is no treatment heterogeneity (i.e., no IV-endogenous treatment
interaction; Terza et al., 2008). Additionally, both the 2SRI and 2SPS approaches
are biased for estimating the causal effects of receiving treatment among compliers
in a randomized trial context (Cai et al., submitted for publication).
Conventionally, a variable is selected as an instrumental variable if it satisfies
the following conditions: 1) it is correlated with the endogenous variable; 2) it affects the outcome only through the endogenous variable; 3) it is uncorrelated with
unmeasured confounders. For condition 1), the correlation between the selected instrumental variable and the endogenous variable should be strong. Otherwise, as
Martens et. al. (2006) have shown, a weak instrumental variable will result in large
standard errors for the IV estimators. Furthermore, only a small violation of IV
assumptions will result in a biased estimate even with a large sample size. Finally,
a weak instrumental variable will result in biased estimates when sample size is
small even when all the assumptions hold. Normally, it is desirable to have strong
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instrumental variables. However, there is a tradeoff between the confounding and
the strength of IV. When confounding is strong and all the IV assumptions hold,
the maximum correlation between the instrumental variables and the endogenous
variable is low. Therefore, Martens et. al. (2006) pointed out that IV approaches
are more useful when confounding strength is moderate but become less useful when
confounding effect is strong. Condition 2) is known as exclusion restriction and we
would also want to estimate the direct causal effect of treatment when this assumption is violated. Condition 3) is ensured by randomization.

1.3

Structural nested mean models

Assuming exclusion restriction, the two linear IV approaches are shown to estimate the causal treatment parameter defined by an additive SNMM (Dunn and
Bentall, 2007). The SNMM has been widely applied in longitudinal studies to define
causal parameters when we have repeated measurements at multiple time points.
It separates the causal effect at each time interval as a function of variables available prior to that interval. It is a semi-parametric model since it merely links the
expected outcome to the causal effects of interest, but does not require the joint
distribution of potential outcomes to be specified. The SNMM is mostly applied in
literature assuming exclusion restriction, and has now been implemented for continuous, count and binary outcomes (Joffe and Brensinger, 2003; Vansteelandt and
Goetghebeur, 2003; Fischer-Lapp and Goetghebeur, 1999; Comté et. al., 2009). To
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estimate the causal parameters defined by SNMMs, a separate weighted estimating
equation is derived for each parameter. Regardless of the magnitude of confounding,
it can be shown that asymptotically unbiased estimators can be obtained by solving
these estimating equations. The estimating procedure is known as the G-estimation
and the resulting estimator is referred as the G-estimator. Among a class of unbiased
estimators, the most efficient estimator in this class can be obtained by deriving the
weight element that corresponds to each causal parameter using Robins’ efficient
score criteria (Robins et. al., 1992). Misspecification of the weight function will only
impact the efficiency of the estimators.

1.4

Mediation analysis

So far the IV approaches and the SNMM/G-estimation are mostly implemented
assuming exclusion restriction. However, the exclusion restriction assumption is not
always applicable. We frame the analysis without the exclusion restriction as a mediation analysis. The goal of our mediation analysis is to estimate the direct effect
of treatment adjusting for an intermediate endogenous variable. The intermediate
endogenous factor is considered as a mediator (Baron and Kenny, 1986; Kraemer et.
al., 2002) because aside from the direct effect, the effect of treatment on the outcome
can be mediated by this factor. In standard mediation analysis, it is often assumed
that there is no unmeasured confounding for both the treatment and the mediator
(i.e, sequential ignorability). Assuming sequential ignorability, Vansteelandt (2009)
8

proposed a log-linear SNMM estimated with sequential G-estimation for the mediation context in the presence of an observed intermediate confounding variable.
In contrast, the assumption of sequential ignorability has been relaxed for causal
log-linear models in the context of adjusting for non-compliance (e.g., Comté et al.,
2009). However, the exclusion restriction assumption is assumed for their approach.

1.5

Contributions of my dissertation

In the context of a randomized clinical trial, my dissertation focuses on relaxing the exclusion restriction assumption by performing mediation analysis. Unlike
the traditional mediation analysis, we do not assume ignorable confounding on the
mediator-outcome relationship. Since treatment randomization occurs in time prior
to the mediator, any inference made for the mediator should incorporate treatment
information. We will use the SNMM to define causal parameters for mediation analyses because it identifies causal effect at each time point as a function of events
available prior to that time interval.
There have been many investigations comparing the IV models and SNMM under non-compliance and under the exclusion restriction assumption, and it is well
known that the IV 2SPS and 2SRI approaches are equivalent under the linear SNMM.
However, there has been no formal analytical evaluation of the relationship between
the two-stage IV approaches and the linear SNMM when relaxing the exclusion restriction and the assumptions of ignorability for the mediator-outcome relationship.
9

Therefore, we analytically and empirically compare the linear SNMM and IV models
by relaxing these two assumptions in the first chapter of my dissertation. The unmeasured confounding resulting from the lack of ignorability for the mediator-outcome
relationship is analytically expressed in terms of the bias in the mediation SNMM.
We show that the two-stage IV approaches appropriately adjust for the bias terms
when estimating the effects of the randomized intervention and the mediator on outcome. In the second chapter, we extend the two IV estimation approaches developed
for linear models to the setting of log-linear SNMM and study their performances in
the presence of unmeasured confounding. While the two two-stage implementations
are equivalent and valid under the linear SNMM, we nonetheless show that they are
not valid under the log-linear SNMM. The bias terms corresponding to unmeasured
confounding of the mediator-outcome relationship are accommodated differently by
the two IV approaches. In the third chapter, given that the IV approaches are invalid
for estimating causal risk ratios, we present a set of weighted G-estimation equations
that yield consistent and asymptotically normal estimators of the causal parameters
defined by the mediation log-linear SNMM without the assumptions of sequential
ignorability and exclusion restriction.
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Chapter 2
Causal Mediation Analyses in
Randomized Clinical Trials Using
Two-Stage Instrumental Variable
Approaches Under a Linear
Structural Nested Mean Model

11

2.1

Introduction

In the context of mediation analyses of the mechanism of randomized interventions on continuous outcomes in randomized trials, we theoretically and empirically
compare the two-stage instrumental variable (IV) approaches and structural nested
mean model (SNMM) for estimating linear direct effects of the randomized intervention on outcome without any assumptions regarding unmeasured confounding of the
mediator-outcome relationship. Ten Have et al. (2007) presented the linear SNMM
approach under no assumptions of unmeasured confounding of the mediator-outcome
relationship. Dunn and Benstall (2007) empirically compared the two-stage IV and
SNMM approaches for assessing post-randomization interactions. While they did
assess the relaxation of the exclusion restriction with a direct effect, they did not
focus on this in terms of their model comparisons. In this paper, we formally develop the IV mediation model in terms of the bias in the mediation SNMM and
thoroughly compare the linear regression and IV estimators in simulations. While
it is well known that the two two-stage implementations, two-stage predictor substitution (2SPS) and two-stage residual inclusion (2SRI), are equivalent under the
linear model, we nonetheless show how they accommodate differently the bias terms
corresponding to unmeasured confounding of the mediator-outcome relationship in
the development under the SNMM. These theoretical relationships are confirmed
empirically with simulation results.
Instrumental variable approaches have been used in the context of structural
12

equation models (e.g., Goldberger, 1972) in the econometrics and epidemiology fields
to assess the effects of endogenous factors, such as exposures to risk factors or nonrandomized treatments, on outcome, while accommodating unmeasured confounding of endogenous factor-outcome relationships. However, these IV methods require
other assumptions some of which are untestable in the observational study. The
crucial untestable assumption is that the IV itself is unrelated to unmeasured confounders of the endogenous factor-outcome relationship or to intermediate factors
in the pathway between the endogenous factor and outcome (exclusion restriction).
However, if the IV is randomized as is the case when it is the randomized intervention
in a randomized trial, the condition of no association with unmeasured confounders
is satisfied, and the exclusion restriction can be assessed with data by creating additional IVs based on interactions between baseline covariates and the randomized
intervention factor. The IV approach has been used in the randomized trial context
to estimate the effect of non-compliance as the endogenous factor effect on outcome,
which has been shown to be the intent-to-treat effect of the randomized intervention
in compliers (e.g, Angrist et al. 1996).
Comparisons of the SNMM and IV approaches for estimating effects of treatment have been limited by the exclusion restriction assumption (i.e, no direct effect
of the randomized treatment). For example, Hernán and Robins (2006) showed such
an equivalence along with the no-interaction assumptions necessary for identifying
the effect of receiving treatment or the intent-to-treat effect in compliers. However,
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there has been no formal evaluation of the relationship between the two-stage IV
approaches and the linear SNMM when relaxing the exclusion restriction and the
assumptions of ignorability for the mediator-outcome relationship. We show analytically that the two-stage IV approaches appropriately adjust for the bias terms
resulting from the lack of ignorability for the mediator-outcome relationship when
estimating the direct effects of the randomized intervention and the mediator on outcome. Furthermore, we numerically evaluate the performance of the IV approaches
in estimating these causal effects under the linear mediation SNMM.
An important but testable assumption for both estimation and the mediation
hypothesis is the association between the IV and endogenous variable. A small
violation of the no-confounding or exclusion restriction assumptions will result in
a biased estimate of the endogenous effect on outcome even with a large sample
size. Additionally, finite sample bias will exist even when all the assumptions hold
(Martens et. al., 2006). The association between the IV and endogenous factor is
very compatible with the mediation requirement that the randomized intervention
(IV) should be associated with the mediator (endogenous variable).
The motivation of our proposed linear mediation approach comes from a randomized clinical trial comparing mortality of advanced non-small-cell lung cancer
(NSCLC) patients randomized to vinorelbine augmentation of standard treatment
with cisplatin to those randomized to no augmentation of cisplatin (Wozniak et.
al., 1998). The mediation hypothesis is that augmentation with vinorelbine reduces
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mortality by reducing tumor size. Accordingly, on the 60th follow-up day after assignment to vinorelbine or no-vinorelbine, all randomized patients were measured
for tumor response and categorized as responders or non-responders. Our analysis
focuses on assessing the direct effect of vinorelbine on outcome besides its effect
through the intermediate factor, tumor response.
In general, we are assuming that the outcome variable is a continuous variable
for a given individual, which justifies the choice of the linear model under which
parameters are interpreted in terms of mean differences. However, for the lung
cancer data, the outcome is binary (death or not). The specification of the linear
model for the individual-level outcome leads to the linear model for the sum of the
individual-level outcomes across subjects within each covariate pattern defined by the
randomized treatment, mediator and baseline covariates, which is more continuous
than the binary individual-level outcome and also is bounded away from 0 and 1 for
most of the covariate patterns. We note that the two-stage IV approaches rely on
asymptotic distributions and the bias results in this paper only rely on first order
moments, such that there are no higher order distribution assumptions required for
the outcome.
This paper is organized as follows. Notation on observed and potential outcome
variables is introduced in section 2. The linear SNMM with the direct effects of the
randomized intervention and mediator on outcome and the assumptions necessary
to identify causal parameters are discussed in sections 3. We evaluate theoretically
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the 2SPS and 2SRI IV estimation approaches in terms of linear SNMM in section 4
and then with simulations in section 5. We illustrate the use of the IV approaches in
the data analysis in section 6. The paper concludes with a discussion of the results
and some future research problems.

2.2

Notation

In this section, we define observed and potential variables for subject i, i =
1, ..., n. All of the following variables apply to the ith of n patients and we suppress
the index i to simplify notation. Let R = 1 if a patient is randomized to the
treatment (e.g., combined treatment of cisplatin and vinorelbine) and R = 0 if a
patient is randomized to the comparison group (e.g., a cisplatin only). For the lung
cancer data, we define a binary mediator although the approaches in this paper
accommodate continuous mediators. Let S = 1 if a patient exhibits level one of the
binary mediator (e.g., tumor response) and S = 0 if he/she exhibits level zero (e.g.,
tumor non-response). For the discussion, we refer to the zero levels of R and S as
“reference” levels. The baseline covariates are denoted by X . Let Y be the binary
outcome variable. Again, we will apply linear model for the sum of the individual
outcomes across subjects within each covariate pattern defined by R, S, and X ,
which is more continuous than the binary individual-level outcome.
To define the causal parameters and state the assumptions necessary to make
valid inference, we use the potential outcomes framework (Holland, 1986). It is as16

sumed that each subject can be potentially exposable to any combination of the
randomized treatment levels (e.g., cisplatin and vinorelbine or cisplatin only) and
mediator levels (e.g., tumor response or non-response). Let Y (r,s) be the outcome
variable that would be observed if subjects were randomized to treatment r and
exhibits mediator level s. For binary treatment assignment and mediator, each subject has four potential outcomes: Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) . The reference potential
outcome Y (0,0) corresponds to the outcome that would be observed for the reference
levels of R and S (e.g., no tumor response on the cisplatin only treatment arm). In
the next section, we will discuss the assumptions used to identify causal parameters.
The direct effect of treatment and mediation effect will be defined under a linear
SNMM.

2.3

Linear SNMM for mediation analysis

In this section we present the linear SNMM with causal direct effects of the
randomized intervention and mediator on the outcome. We first, however, present
the assumptions necessary to identify and obtain asymptotically unbiased estimates
of the causal effects.
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2.3.1

Assumptions

To identify the causal effects of interest in terms of potential outcomes under
the linear SNMM, we first introduce the corresponding assumptions necessary for
unbiased inference. The required assumptions are 1) the stable unit treatment value
assumption (SUTVA; Rubin, 1986; Angrist et al., 1996); 2) randomization of treatment assignment; and 3) a number of no-interaction assumptions.
We consider the two components of SUTVA. First, the treatment assignment
and level of the mediator for one subject does not influence the outcomes of others.
That is, there is a single value for each of the potential random outcome variables
(Y (r,s) ) for a given patient i regardless of the randomization assignment or mediation
behavior of any other patient i′ . Notationally, we can denote the potential outcomes
for subject i as scalar indices Y (r,s) , rather than Y (rr ,ss) that takes n-dimensional vector indices of treatment and tumor response of all subjects into account. For our
example, it is likely that this part of SUTVA holds, unless an oncologist sees multiple study patients and alters some aspect (e.g., dose) of the treatment in reaction
to the overall response (e.g., side effects) from the previous patients receiving the
treatment. Second, only one of the potential outcomes will be the observed outcome
for each subject even if the treatment assignment or tumor response occurrence
varies (“consistency”; Rubin, 1986). This assumption allows us to link the potential
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outcomes to the observed outcome:

Y = rsY (1,1) + (1 − r)sY (0,1) + r(1 − s)Y (1,0) + (1 − r)(1 − s)Y (0,0) .

For the randomization assumption,

E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | R = r, X = x) = E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | X = x).

Under this assumption, the first order moments of the potential outcomes and by
definition observed and unobserved baseline covariates should be equal between the
randomized intervention groups.
To achieve identifiability of the causal effects of R and S under the proposed
mediation SNMM, certain no-interaction assumptions are also needed (e.g., Ten
Have et al., 2007; Hernán and Robins, 2006). The first no-interaction assumption is
that there is no causal linear interaction between the randomized intervention and
mediator. That is, there is no structural interaction term between R and S in the
proposed SNMM which would correspond to:

X = x , R = r, S = s) − E(Y (1,0) |X
X = x , R = r, S = s)
E(Y (1,1) |X
X = x , R = r, S = s) − E(Y (0,0) |X
X = x , R = r, S = s)
= E(Y (0,1) |X

for all r, s, and x .
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The second set of no-interaction assumptions requires that the causal linear main
effects of R and S must not differ across observed groups of subjects defined by
the observed levels of R and/or S. A representative no-interaction indicating no
difference of the causal main effect of R between two groups of subjects defined by
R = 1 and R = 0 is presented as follows:

X = x , R = 1, S = s′ ) − E(Y (0,s) |X
X = x , R = 1, S = s′ )
E(Y (1,s) |X
X = x , R = 0, S = s′ ) − E(Y (0,s) |X
X = x , R = 0, S = s′ )
= E(Y (1,s) |X

for all x, s (which is the set indices of S), s′ (which is the observed value of S defining
the sub-group).
Similar no-interaction equalities are needed when the sub-groups are differentiated by different values of S rather than R. These equalities are not testable because
of the necessity of stratifying on S and thus requiring that the randomization assumption for R hold for sub-groups defined by S, which is unfeasible under the
current set of assumptions. Hence, these interactions that are assumed to be zero
are not identifiable without further assumptions. For the second set of no-interaction
assumptions, the main causal effects of R and S are assumed not to vary between
different groups distinguished by the levels of the elements of X . We can theoretically stratify the sample by X and estimate the above interaction and then test if
the causal main effects of R and S are statistically different across these strata, if
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of course there are sufficient subjects. Moreover, one can code the specific variable
elements of X such that the causal effects are interpreted as a weighted average
across the levels of these variable elements (e.g., Bond et al. 2007).

2.3.2

Model

The proposed mediation model belongs to the general class of linear structural
nested mean models for longitudinal data (Robins, 1994, 1997; Robins et al., 1999).
The model is “nested” in the sense that at each time point, we only condition on
information that is available according to the current measured “treatment” history.
In the mediation context, “treatment” pertains to the randomized intervention at
time 1 and then the mediator at time 2. Apart from baseline covariates, we condition
on the randomized intervention at time 2 when assessing the effect of the mediator
on outcome. Whereas when assessing the effect of the randomized intervention at
time 1, we do not condition on any previous “treatment”. In terms of the lung cancer
data, since tumor response occurs after randomization, the effect of the randomized
treatment under the linear SNMM is not conditional on tumor response, whereas
the effect of tumor response is conditional on the randomized treatment assignment.
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These casual effects are parameterized in the following linear SNMM:

X = x, R = r, S = s) = E(Y (0,0) |X
X = x)
E(Y (r,s) |X


X = x , R = 0) − E(Y (0,0) |X
X = x)
+ E(Y (0,0) |X


X = x , R = r) − E(Y (0,0) |X
X = x , R = 0)
+ E(Y (0,0) |X


X = x , R = r) − E(Y (0,0) |X
X = x , R = r)
+ E(Y (r,0) |X


X = x , R = r, S = 0) − E(Y (r,0) |X
X = x , R = r)
+ E(Y (r,0) |X


X = x , R = r, S = s) − E(Y (r,0) |X
X = x , R = r, S = 0)
+ E(Y (r,0) |X


X = x , R = r, S = s) − E(Y (r,0) |X
X = x , R = r, S = s)
+ E(Y (r,s) |X
X = x ) + Γ1 (x
x) + q1 (x
x, r) + γ1 (x
x, r)
= E(Y (0,0) |X
x, r) + q2 (x
x, r, s) + γ2 (x
x, r, s)
+Γ2 (x

(2.3.1)

where

x) = E(Y (0,0) |X
X = x , R = 0) − E(Y (0,0) |X
X = x)
Γ1 (x
x, r) = E(Y (0,0) |X
X = x , R = r) − E(Y (0,0) |X
X = x , R = 0)
q1 (x
x, r) = E(Y (r,0) |X
X = x , R = r) − E(Y (0,0) |X
X = x , R = r)
γ1 (x
x, r) = E(Y (r,0) |X
X = x , R = r, S = 0) − E(Y (r,0) |X
X = x , R = r)
Γ2 (x
x, r, s) = E(Y (r,0) |X
X = x , R = r, S = s) − E(Y (r,0) |X
X = x , R = r, S = 0)
q2 (x
x, r, s) = E(Y (r,s) |X
X = x , R = r, S = s) − E(Y (r,0) |X
X = x , R = r, S = s)
γ2 (x
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In general, the mean of the observed outcome for a patient with assignment r
and mediator level s can be parameterized as the reference potential outcome plus a
x) is the bias parameter reflecting the
series of effects related to R and S, where Γ1 (x
x, r) and q2 (x
x, r, s)
how the control group is different from the overall population; q1 (x
x, r) is the causal
are selection bias and unmeasured confounding parameters; γ1 (x
x, r) is the effect of R, adjusting for S versus not adjusting
direct effect of R; Γ2 (x
x, r, s) is the causal effect of S fixing R. The functions γ1 (x
x, r) and
for S; and γ2 (x
x, r, s) are known as Robins’ blip functions (Robins, 1994, 2008) and the functions
γ2 (x
x), q1 (x
x, r), Γ2 (x
x, r), and q2 (x
x, r, s) are defined such that the right hand side of
Γ1 (x
X = x , R = r, S = s). It directly
the equation is equal to the left hand side E(Y (r,s) |X
x, 0) = γ2 (x
x, r, 0) = 0.
follows from the model that γ1 (x
X , R) + q2 (X
X , R, S) denotes the effect of unmeasured conThe parameter Γ2 (X
founders on outcome.

X , R) and q2 (X
X , R, S)
According to the definition of Γ2 (X

for linear SNMM (Robins et. al., 1999), we can obtain an explicit expression for
X , R) + q2 (X
X , R, S) by noting the following relationship
Γ2 (X

x, r) = −ES (q2 (X
X , R, S)|X
X = x , R = r) .
Γ2 (x

X = x , R = r, S) = δ X x + δR r + δS S. The
Assuming linear main effects, let E(Y (r,0) |X
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X , R, S) can be expressed as
function q2 (X

x, r, S) = E(Y (r,0) |X
X = x, R = r, S) − E(Y (r,0) |X
X = x, R = r, S = 0)
q2 (x
= (δδ X x + δR r + δS S) − (δδ X x + δR r)
= δS S.

Therefore,

x, r) + q2 (x
x, r, S)
Γ2 (x
x, r, S) − ES (q2 (X
X , R, S)|X
X = x , R = r)
= q2 (x
X = x , R = r)].
= δS [S − E(S|X

x) = q1 (x
x, r) = 0. By SUTVA,
Under the randomization assumption, Γ1 (x

X = x , R = r, S = s) = E(Y |X
X = x , R = r, S = s).
E(Y (r,s) |X

X , R) + q2 (X
X , R, S), the linear
Under these assumptions and the expression for Γ2 (X
SNMM in equation (2.3.1) can be rewritten as

X = x , R, S)
E(Y |X
X = x ) + θR R + θS S + δS [S − E(S|X
X = x , R)]
= E(Y (0,0) |X
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(2.3.2)

x, R) is parameterized as θR R and γ2 (x
x, R, S) is parameterized as θS S. The
where γ1 (x
parameter θR represents the direct effect of randomized treatment on outcome; and
θS represents the effect of mediator on outcome holding randomized treatment fixed
at any level r. We will show in the next section that unbiased parameter estimates
can be obtained using the two-stage IV approaches under the linear SNMM defined
in equation (2.3.2).

2.4

IV estimation relationship with SNMM

For IV estimation of θR and θS , at least two instruments are required to identify
and obtain asymptotically unbiased estimators of these casual effects. The randomization variable and its interaction with a baseline covariate may serve as the two
X , R) as the predicted value based on the
instrumental variables. We denote Ê(S|X
first stage model, which in the case of binary S can be fitted with a model such as
the logistic model.
In the second-stage regression of the outcome on the randomized intervention and
X , R) for the
mediator, we replace the tumor response S by its predicted value Ê(S|X
2SPS approach. In contrast, instead of replacing S in the second-stage estimation,
X , R) as a covariate in addition to
the 2SRI regression includes the residual S − Ê(S|X
S. The SNMM parameterization in equation (2.3.2) is exactly the 2SRI second-stage
regression, so the 2SRI approach yields unbiased estimates. The 2SPS approach is
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based on the following second-stage model:

X = x, R) = E(Y (0,0) |X
X = x) + θR R + θS E(S|X
X = x, R)
E(Y |X

which can be obtained by taking the double expectation over S given (xx, R) from
X , R) +
equation (2.3.2). Note that the unmeasured confounding parameters, Γ2 (X
X , R, S), in the linear SNMM disappear from the 2SPS model because
q2 (X

X , R) + q2 (X
X , R, S)|X
X = x , R) = δs E[S − E(S|X
X = x , R)|X
X = x , R] = 0.
E(Γ2 (X

Thus, the estimators obtained from the 2SPS approach are unbiased. Hence, for mediation analyses under the linear SNMM, the 2SPS and 2SRI estimation approaches
adjust for the unmeasured confounding parameters in the SNMM and thus yield
unbiased estimators of the θR and θS parameters.

2.5

Simulation

In this simulation study, the goal is to perform mediation analyses based on linear
SNMM to investigate the consistency of estimators obtained from standard ordinary
least squares (OLS) regression and the 2SPS and 2SRI IV approaches in the presence
of unmeasured confounding. To investigate the small versus large sample properties
of these estimators, we carry out simulation studies using 358 and 2000 subjects,
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each with 1000 replications. The sample size N = 358 is the size of the lung cancer
data and N = 2000 is chosen to show the asymptotic properties of the IV estimators.
Under each setting, we explore how well these approaches do with varying levels of
unmeasured confounding, as parameterized by δS . For each subject, the variables
were simulated based on the linear SNMM in equation (2.3.2) for the outcome and
the first stage model for S with the following algorithm:
1. Generate a bernoulli randomized treatment R with 0.5 success probability and
a bernoulli baseline covariate X with 0.7 success probability.
2. Generate a bernoulli mediator, S, with success probability

X , R) = expit{β0 + βR R + βX X + βRX RX}
E(S|X

where R and RX are selected instruments that are correlated with S.
X = x , R).
3. Calculate the unmeasured confounding U = S − E(S|X
4. Based on the linear SNMM, generate a continuous outcome Y that follows a
normal distribution with variance one and mean

X , R, S) = θ0 + θX X + θR R + θS S + δS U
E(Y |X

where δS takes the values between 0 and 2, increment by 0.2 at a time.
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5. Then perform linear regression, 2SPS and 2SRI analyses using the simulated
variables.
Separately for N = 358 and N = 2000, comparisons of bias, MSE, and % coverage (the proportion of iterations which the 95% confidence intervals cover the true
parameters θR and θS ) among the three approaches are displayed in Table 2.1 and
Table 2.2 by varying the strength of unmeasured confounding δS . The corresponding
bias plots are presented in Figure 2.1 and Figure 2.2. The IV estimates for N = 358
are similar to those for N = 2000 with no to moderate confounding (δS <= 1.0)
for both the θR and θS parameters. For strong confounding (δS > 1.0), the θR
estimator (direct effect of the randomized intervention) is not much more biased
under N = 358 than under N = 2000. However, the θS estimator is much more
biased under N = 358 than N = 2000 for strong confounding. We now focus on
the N = 2000 results. The linear regression gives unbiased estimates when there
is no confounding, but the biases for the effects of treatment and tumor response
increase linearly as the strengths of confounding increase. The bias for the randomized treatment effect is smaller than the bias for the effect of mediator on outcome.
The 2SPS and 2SRI approaches yield unbiased estimates of θR and θS regardless
of the strength of unmeasured confounding. For all the three approaches, the MSE
increases as the magnitudes of confounding increases, and the MSE for the randomized treatment effect is smaller than the MSE for the mediator effect. The two IV
approaches have smaller MSE than those from linear regression when the strength of
28

confounding is moderate to large (0.4 < δS < 2.0). The 95% confidence interval coverage under linear regression is very good when there is no unmeasured confounding.
However, coverage decreases dramatically to zero with increasing confounding. In
contrast, coverage under the IV approaches is very good regardless of the magnitude
of confounding. Additionally, the results for the treatment and mediator effects are
the same between the two IV approaches because of their equivalence. Finally, we
have also tried negative confounding values and the results are symmetric, so the
conclusions are the same as those with positive confounding values.
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Table 2.1: A comparison of bias, mean square errors and 95 % confidence interval coverage using linear regression, 2SPS, and 2SRI approaches under linear SNMM. The sample size is 358 using 1000 replications. The parameters are
(β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.2, 0.1, −0.2, 0.5).
Linear

Bias
2SPS

2SRI

θR
θS

0.00
-0.00

0.01
-0.02

0.01
-0.01

θR
θS

-0.08
0.19

0.02
-0.03

θR
θS

-0.16
0.39

0.03
-0.05

θR
θS

-0.25
0.58

0.01
-0.04

θR
θS

-0.33
0.78

0.04
-0.08

θR
θS

-0.43
0.97

0.00
-0.03

θR
θS

-0.51
1.16

0.06
-0.14

θR
θS

-0.58
1.35

0.08
-0.19

θR
θS

-0.67
1.55

0.04
-0.10

θR
θS

-0.75
1.73

0.07
-0.15

θR
θS

-0.82
1.93

0.08
-0.17

Linear

MSE
2SPS

2SRI

Setting 1: δS = 0
0.01
0.17 0.17
0.02
0.85 0.85
Setting 2: δS = 0.2
0.02
0.02
0.16 0.16
-0.03
0.06
0.80 0.80
Setting 3: δS = 0.4
0.03
0.04
0.18 0.18
-0.05
0.17
0.89 0.89
Setting 4: δS = 0.6
0.01
0.08
0.32 0.32
-0.04
0.35
1.72 1.72
Setting 5: δS = 0.8
0.04
0.13
0.20 0.20
-0.08
0.62
1.00 1.00
Setting 6: δS = 1.0
0.00
0.20
0.21 0.21
-0.03
0.95
1.01 1.01
Setting 7: δS = 1.2
0.06
0.27
0.23 0.23
-0.14
1.37
1.17 1.17
Setting 8: δS = 1.4
0.08
0.35
0.36 0.36
-0.19
1.85
1.87 1.87
Setting 9: δS = 1.6
0.04
0.46
0.21 0.21
-0.10
2.41
1.08 1.08
Setting 10: δS = 1.8
0.07
0.58
1.03 1.03
-0.15
3.03
5.03 5.03
Setting 11: δS = 2.0
0.08
0.70
0.31 0.31
-0.17
3.76
1.50 1.50
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Figure 2.1: A comparison of bias using linear regression, 2SPS, and 2SRI approaches
under linear SNMM. The sample size is 358 using 1000 replications. The parameters
are (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.2, 0.1, −0.2, 0.5).
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Table 2.2: A comparison of bias, mean square errors and 95 % confidence interval coverage using linear regression, 2SPS, and 2SRI approaches under linear
SNMM. The sample size is 2000 using 1000 replications. The parameters are
(β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.2, 0.1, −0.2, 0.5).
Linear

Bias
2SPS

2SRI

θR
θS

-0.00
0.00

0.00
-0.01

0.00
-0.01

θR
θS

-0.08
0.19

0.01
-0.02

θR
θS

-0.17
0.39

0.01
-0.02

θR
θS

-0.25
0.58

-0.00
0.00

θR
θS

-0.33
0.77

0.00
-0.01

θR
θS

-0.42
0.97

-0.00
0.01

θR
θS

-0.50
1.16

0.00
-0.01

θR
θS

-0.58
1.35

0.01
-0.01

θR
θS

-0.67
1.54

0.01
-0.03

θR
θS

-0.75
1.74

0.01
-0.02

θR
θS

-0.83
1.93

0.02
-0.04

Linear

MSE
2SPS

2SRI

Setting 1: δS = 0
0.00
0.02 0.02
0.00
0.11 0.11
Setting 2: δS = 0.2
0.01
0.01
0.02 0.02
-0.02
0.04
0.11 0.11
Setting 3: δS = 0.4
0.01
0.03
0.02 0.02
-0.02
0.15
0.11 0.11
Setting 4: δS = 0.6
-0.00
0.07
0.02 0.02
0.00
0.34
0.12 0.12
Setting 5: δS = 0.8
0.00
0.11
0.02 0.02
-0.01
0.60
0.11 0.11
Setting 6: δS = 1.0
-0.00
0.18
0.03 0.03
0.01
0.94
0.12 0.12
Setting 7: δS = 1.2
0.00
0.25
0.03 0.03
-0.01
1.35
0.13 0.13
Setting 8: δS = 1.4
0.01
0.34
0.03 0.03
-0.01
1.84
0.14 0.14
Setting 9: δS = 1.6
0.01
0.45
0.03 0.03
-0.03
2.39
0.14 0.14
Setting 10: δS = 1.8
0.01
0.56
0.03 0.03
-0.02
3.03
0.16 0.16
Setting 11: δS = 2.0
0.02
0.70
0.03 0.03
-0.04
3.74
0.17 0.17
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Figure 2.2: A comparison of bias using linear regression, 2SPS, and 2SRI approaches
under linear SNMM. The sample size is 2000 using 1000 replications. The parameters
are (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.2, 0.1, −0.2, 0.5).
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2.6

Data analysis

To illustrate the use of the IV approaches in the mediation context, we apply the
linear regression, 2SPS, and 2SRI procedures to the lung cancer data to estimate the
effects of treatment and tumor response. The outcome of interest is patient’s survival
status (alive or dead) determined at the 8th month after treatment randomization.
The baseline covariate is performance status (Xs ), where Xs = 1 if performance status is restricted or no effect and Xs = 0 if performance status is fully active. Among
different covariate patterns defined by treatment, tumor response, and performance
status, since most of the proportions of death (5 out of the total of 8 combinations)
are between 0.3 and 0.7, we can apply linear regression model to this binary data
(Agresti, 2000; p. 120). Totally 414 subjects are recruited at the beginning, but
only 358 subjects who are alive at the intermediate endpoint (60 days after randomization) are included in the analyses. For those subjects, it is shown in the
exploratory analyses that treatment assignment is not significantly associated with
the performance status (p = 0.23) and therefore we cannot reject the possibility that
the randomization assumption is valid. Furthermore, for subjects who are excluded
from the analyses, there is no significant difference (p = 0.69) in survival between
the two treatment groups.
We now consider the mediation analyses based on the linear regression and the
corresponding IV approaches. In the first stage of the two IV methods, the number
of instruments should be equal or greater than the number of causal parameters
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in order to have identifiable causal effects. We need at least two instruments for
mediation analyses and they should be strong predictors of tumor response. After
a series of exploratory analyses, the expected tumor response is estimated from the
following model

h
i
ˆ R) = −1.95 − 0.84R − 0.08Xs + 1.76RXs ,
logit E(S|X,
where RXs is the interaction between randomized treatment and performance status.
While the effect of R is not significant (p = 0.20), the effect of RXs is significant
(p = 0.02) on the tumor response. We select both R and RXs as instruments for
the prediction of tumor response.
For linear regression and the second stage of the IV methods, we regress the
outcome on treatment, tumor response, and performance status. The estimated
effects of treatment and tumor response of all the three approaches are displayed
in Table 2.3. As we expect, both the IV methods yield the same estimates and the
results are different from those based on the linear regression. There is a significant
effect of tumor response (p = 0.01) from the linear regression while it becomes clearly
non-significant using the IV approaches (p = 0.57). The non-significance occurs both
because of a large increase in standard error under the IV approaches, but at the same
time, the effect of tumor response switches in sign from the linear regression estimate,
strongly suggesting that the effect may be indeed non-significant. In contrast, the
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standard regression and IV estimates of the direct effect of randomized vinorelbine
augmentation on survival are more similar, -0.08 vs. -0.11, respectively. Unlike the
IV estimates of the tumor response effect, the standard error for the IV estimate
of vinorelbine augmentation is similar to that of the linear regression. Hence, the
somewhat larger IV estimate of direct effect of vinorelbine augmentation leads to a
more significant p-value (p = 0.09) relative to that of the linear regression (p = 0.14).
To investigate whether adjusting for tumor response reduces the effect of vinorelbine augmentation thus suggesting at least partial mediation, the intent-totreat estimate of vinorelbine augmentation not adjusting for tumor response is -0.09
(standard error = 0.05; p = 0.08) which is very similar to the IV estimate of -0.11
(standard error = 0.07; p = 0.09) and linear regression estimate of -0.08 (standard
error = 0.05; p = 0.14) for the direct effect of treatment adjusting for the tumor
response. Consequently, there appears to be very little mediation by tumor response
for the effect of vinorelbine augmentation on survival outcome. This is confirmed by
the lack of significance of tumor response on outcome under the IV approaches, but
not under the linear regression approach.
Overall, the linear regression and IV approaches lead to a mixed set of results depending on which effect is being estimated. For the effect of the potential mediator,
tumor response, on outcome, the approaches dramatically differ. In contrast, for the
effect of the randomized treatment, vinorelbine augmentation, the two approaches
lead to more similar results except in terms of the level of significance. These dif-

36

Table 2.3: Mediation analysis for treatment and tumor response using linear regression, 2SPS, and 2SRI methods.

θR
θS

Mediation Analysis for treatment and tumor response
Linear
2SPS
2SRI
Estimate Error
p
Estimate Error
p
Estimate Error
-0.08
0.05 0.14
-0.11
0.07 0.09
-0.11
0.07
-0.27
0.07 0.01
0.34
0.60 0.57
0.34
0.60

p
0.09
0.57

ferences between the two approaches could be due to the presence of unmeasured
confounding of the tumor response-outcome relationship and/or due to the presence
of a causal interaction between the vinorelbine and tumor response on outcome. A
naive analysis of this interaction based on linear regression yields a point estimate of
0.24 with a p-value of 0.11, suggesting that there is no significant causal interaction.

2.7

Discussion

We have shown that for estimating the effects of a randomized intervention and
mediator on outcome, the two-stage IV 2SPS and 2SRI approaches adjust for the unmeasured confounding components of the mediator-outcome relationship under the
linear SNMM. Therefore, the two-stage IV methods are a valid estimation approach
under the linear SNMM without the assumption of ignorability for the mediator
effect on outcome and exclusion restriction. The tradeoff for relaxing these assumptions is that the resulting estimators have larger mean squared errors than does the
standard OLS when confounding does not exist or is weak. Hence, when there is
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no unmeasured confounding, standard linear regression is preferred. However, as
we have shown in simulation studies that the MSE for OLS exceeds that for the IV
approaches when confounding is strong.
Choosing appropriate instruments is important for IV approaches in obtaining
unbiased estimates. We have considered the implementation of IV approaches in
the context of a randomized clinical trial. The advantage of randomization is that
the randomized treatment itself and its interactions with other baseline covariates
can serve as instruments. However, in observational studies where unmeasured confounding potentially exists for the IV-outcome or IV-mediator relationships, it may
be difficult to find appropriate instruments because only a limited number of variables are available as candidate instruments. Recommendations on obtaining valid
instruments and the drawbacks of having poorly selected instruments have been
investigated for observational studies (Martens et al., 2006).
So far, our discussions on mediation analyses are based on linear SNMM with
main effects. Future research will focus on linear SNMMs that include structural
interactions between the randomized treatment and mediator for mediation analyses.
In addition, various estimation approaches have been discussed under log-linear and
logistic SNMMs assuming exclusion restriction for estimating the causal effect of
treatment received under non-compliance in randomized trials (Vansteelandt and
Goetghebeur, 2003; Ten Have et al., 2003; Comté et al., 2009). Extensions of loglinear and logistic SNMMs for mediation analyses are topics for future investigation.
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Chapter 3
Validity of Causal Inference Using
Two-Stage Instrumental Variable
Approaches Under a Log-linear
Structural Nested Mean Model
When Unmeasured Confounding is
Present
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3.1

Introduction

In this paper, we show that the two-stage instrumental variable (IV) estimation approaches developed for linear models are biased under a log-linear structural
nested mean model (SNMM; Robins, 1994, 1997; Robins et al., 1999) without the
no unmeasured confounding assumption for the endogenous variable (i.e., without
sequential ignorability) and additionally without the exclusion restriction assumption when the IV is the randomized treatment in a randomized trial. We frame the
case without the exclusion restriction as a mediation hypothesis: testing the direct
effect of the randomized treatment adjusting for the mediator, and vice-versa.
We formally investigate the validity of the two-stage predictor substitution (2SPS)
and two-stage residual inclusion (2SRI) approaches in estimating the causal risk ratios when unmeasured confounders of the mediator-outcome relationship exist (i.e.,
no sequential ignorability) under log-linear SNMMs with and without assuming exclusion restriction. We frame the context without the exclusion restriction in terms
of estimating the direct effect of a randomized intervention on count outcomes adjusting for an intermediate factor (i.e., mediator). While it is well known that the
two two-stage implementations are equivalent and valid under the linear model, we
nonetheless show that they are not valid under the log-linear SNMM. The bias terms
corresponding to unmeasured confounding of the mediator-outcome relationship are
accommodated differently by the two IV approaches. These theoretical relationships
are confirmed empirically with simulation results.
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For analyzing continuous outcome data, the 2SPS and 2SRI approaches are attractive because they yield consistent estimators of the additive treatment effect
in the presence of unmeasured confounding (Nagelkerke et. al., 2000). These IV
approaches have been used in the context of structural equation models (e.g., Goldberger, 1972) in the econometrics and epidemiology fields to assess the effects of
endogenous factors, such as exposures to risk factors or non-randomized treatments,
on outcome, while accommodating unmeasured confounding of endogenous factoroutcome relationships. Additionally, the IV approach has been used in the randomized trial context to estimate the effect of non-compliance as the endogenous factor
effect on outcome, which has been shown to be the intent-to-treat effect of the randomized intervention in compliers (e.g, Angrist et al., 1996). If the IV is randomized
as is in our case, the condition of no association with unmeasured confounders is
satisfied, and the exclusion restriction can be assessed with data by creating additional IVs based on interactions between baseline covariates and the randomized
intervention factor (e.g., Ten Have et al., 2007). However, there is less confidence in
an observational study to assume that IVs are unrelated to unmeasured confounders.
In such case, creating new IVs from IV-baseline factor interactions is not as valid as
it is in a randomized trial.
An important but testable assumption for both estimation and the mediation
hypothesis is the association between the IV and endogenous variable. If the association is weak, a small violation of the no-confounding or exclusion restriction
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assumptions will result in a biased estimate of the endogenous effect on outcome
even with a large sample size. Additionally, finite sample bias will exist even when
all the assumptions hold (Martens et. al., 2006). The association between the IV
and endogenous factor is very compatible with the mediation requirement, which
says that the randomized intervention (IV) should be associated with the mediator
(endogenous variable).
When analyzing binary data assuming the exclusion restriction, the 2SRI IV approach has been shown to be unbiased in contrast to the 2SPS approach, with respect
to the causal effect of receiving treatment conditional on the unobserved confounder
when there is no treatment heterogeneity (i.e., no IV-endogenous treatment interaction; Terza et al., 2008). Additionally, both the 2SRI and 2SPS approaches are
biased for estimating the causal effects of receiving treatment among compliers in a
randomized trial context (Cai et al., submitted for publication). Under generalized
linear models such as the log-linear model, Johnston et al. (2008) showed that when
there is no treatment heterogeneity, the generalized method of moments (GMM) approach to IV estimation yields an unbiased estimator of the effect of receiving treatment. Their simulations (p. 1548; item 3) assumed that this confounder-outcome
relationship was at most 17% of the specified endogenous treatment-outcome effect.
We formally investigate a range of feasible confounder-outcome relationships that
do lead to more bias.
An alternative solution to the control of unmeasured confounding is the structural
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nested mean models (SNMMs). Assuming the exclusion restriction, the SNMMs have
been implemented for continuous, count and binary outcomes (Fischer-Lapp and
Goetghebeur, 1999; Vansteelandt and Goetghebeur, 2003; Comté et. al., 2009). The
two linear IV approaches have been shown to yield consistent estimators of the causal
effect under the linear SNMM when exclusion restriction is assumed (Hernán and
Robins, 2006; Dunn and Bentall, 2007). The equivalence still holds without assuming
exclusion restriction (Wang et al., in preparation). Vansteelandt (2009) proposed a
log-linear SNMM estimated with sequential G-estimation for the mediation context
in the presence of an observed intermediate confounding variable. No unmeasured
confounding for both the randomized intervention and the mediator in terms of their
effects on outcome (i.e., sequential ignorability) was assumed.
Under the log-linear SNMM in the randomized trial context where the randomized intervention is a valid IV that has no relationship with unmeasured confounders,
we present a log-linear SNMM that facilitates analytic expressions for bias under unmeasured confounding of the endogenous factor-outcome relationship and departures
from the exclusion restriction. None of the previous investigations have considered
IV estimation without both the unmeasured confounding assumption for the endogenous factor-outcome relationship and the exclusion restriction.
The motivation of our proposed investigation comes from a randomized clinical
trial comparing mortality of advanced non-small-cell lung cancer (NSCLC) patients
randomized to vinorelbine augmentation of standard treatment with cisplatin to
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those randomized to no augmentation of cisplatin (Wozniak et. al., 1998). The
mediation hypothesis is that augmentation with vinorelbine reduces mortality by
reducing tumor size. Accordingly, on the 60th follow-up day after assignment to
vinorelbine or no-vinorelbine, all randomized patients were measured for tumor response and categorized as responders or non-responders. Our analysis focuses on
assessing other unknown pathways for vinorelbine by estimating its direct effect on
outcome around the intermediate factor, tumor response.
In general, we are assuming that the outcome variable is a count variable for
a given individual, which justifies the choice of the log-linear model under which
parameters are interpreted in terms of risk ratios. However, for the lung cancer
data, the outcome at the individual level is binary (death or not). The specification
of the log-linear model for the individual-level outcome leads to the log-linear model
with the same covariate effects for the sum of the individual-level outcomes across
subjects within each covariate pattern, which is a count variable. We note that
the two-stage IV approaches rely on asymptotic distributions and the bias results
in this paper only rely on first order moments, such that there are no higher order
distribution assumptions required for the outcome.
The remainder of the paper is organized as follows. In Section 2, we introduce the
notation. The assumptions necessary for parameter estimation and identifiability are
stated in Section 3. We then describe the two IV methods established for confounding
adjustment in Section 4. We start our discussions on the IV analysis under log-linear
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SNMM by relaxing the exclusion restriction condition in section 5, followed by the
analysis assuming exclusion restriction in Section 6. The bias analysis for the two
IV approaches are presented in Section 7. In Section 8, we illustrate the IV methods
in a lung cancer data. Discussions and concluding remarks are given in Section 9.

3.2

Notation

In this section, we define observed and potential variables for subject i, i =
1, ..., n. All of the following variables apply to the ith of n patients and we suppress
the index i to simplify notation. Let R = 1 if a patient is randomized to the
treatment (e.g., combined treatment of cisplatin and vinorelbine) and R = 0 if a
patient is randomized to the comparison group (e.g., a cisplatin only). For the lung
cancer data, we define a binary mediator although the approaches in this paper
accommodate continuous mediators. Let S = 1 if a patient exhibits level one of
the binary mediator (e.g., tumor response) and S = 0 if he/she exhibits level zero
(e.g., tumor non-response). For the discussion, we refer to the zero levels of R and
S as “reference” levels. The baseline covariates are denoted by X . Let Y be the
outcome variable. For the lung cancer data, Y is binary at the individual level
but the same causal parameters under the log-linear SNMM apply to the counts of
death among different covariate patterns defined by treatment, tumor response, and
baseline covariates. Our analyses are based on these counts.
To define the causal parameters and state the assumptions necessary to make
45

valid inference, we use the potential outcomes framework (Holland, 1986). It is assumed that each subject can be potentially exposable to any combination of the
randomized treatment levels (e.g., cisplatin and vinorelbine or cisplatin only) and
mediator levels (e.g., tumor response or non-response). Let Y (r,s) be the outcome
variable that would be observed if subject i were randomized to treatment r and
exhibits mediator level s. For binary treatment assignment and mediator, each subject has four potential outcomes: Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) . The reference potential
outcome Y (0,0) corresponds to the outcome that would be observed for the reference
levels of R and S (e.g., no tumor response on the cisplatin only treatment arm).

3.3

Assumptions

To identify the causal effects of interest in terms of potential outcomes under
the log-linear SNMM, we first introduce the corresponding assumptions necessary
for unbiased inference. The required assumptions are 1) the stable unit treatment
value assumption (SUTVA; Rubin, 1986; Angrist et al., 1996); 2) randomization of
treatment assignment; and 3) a number of no-interaction assumptions.
We consider the two components of SUTVA. First, the treatment assignment
and the level of mediator for one subject does not influence the outcomes of others.
That is, there is a single value for each of the potential random outcome variables
(Y (r,s) ) for a given patient i regardless of the randomization assignment or mediation
behavior of any other patient i′ . Notationally, we can denote the potential outcomes
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for subject i as scalar indices Y (r,s) , rather than Y (rr ,ss) that takes n-dimensional vector
indices of treatment and mediator of all subjects into account. For our example, it is
likely that this part of SUTVA holds, unless an oncologist sees multiple study patients
and alters some aspect (e.g., dose) of the treatment in reaction to the overall response
(e.g., side effects) from previous patients receiving the treatment. Second, only one
of the potential outcomes will be the observed outcome for each subject even if the
treatment assignment or tumor response occurrence varies (“consistency”; Rubin,
1986). This assumption allows us to link the potential outcomes to the observed
outcome:

Y = rsY (1,1) + (1 − r)sY (0,1) + r(1 − s)Y (1,0) + (1 − r)(1 − s)Y (0,0) .

We propose the following specification of the randomization assumption for unbiasedness of IV model:

log{E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | R = r, X = x)}
= log{E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | X = x)}.

Under this assumption, the first order moments of the potential outcomes and by
definition observed and unobserved baseline covariates should be equal between the
randomized intervention groups.
To achieve identifiability of the causal effects of R and S under the proposed
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mediation SNMM, certain no-interaction assumptions are also needed (e.g., Ten Have
et al., 2007; Hernán and Robins, 2006). The first no-interaction assumption is that
there is no causal multiplicative or log-linear interaction between the randomized
intervention and mediator. That is, there is no structural interaction term between
R and S in the proposed SNMM which would correspond to:

X = x , R = r, S = s)} − log{E(Y (1,0) |X
X = x , R = r, S = s)}
log{E(Y (1,1) |X
X = x , R = r, S = s)} − log{E(Y (0,0) |X
X = x , R = r, S = s)}
= log{E(Y (0,1) |X

for all r, s, and x.
A second set of no-interaction assumptions requires that the causal multiplicative
or log-linear main effects of R and S must not differ across observed groups of subjects defined by the observed levels of R and/or S. A representative no-interaction
indicating no difference between the causal main effect of R between two groups of
subjects defined by R = 1 and R = 0 is presented as follows:

X = x , R = 1, S = s′ )} − log{E(Y (0,s) |X
X = x , R = 1, S = s′ )}
log{E(Y (1,s) |X
X = x , R = 0, S = s′ )} − log{E(Y (0,s) |X
X = x , R = 0, S = s′ )}
= log{E(Y (1,s) |X

for all x , s (which is the set indices of S), s′ (which is the observed value of S defining
the sub-group). Similar no-interaction equalities are needed when the sub-groups are
differentiated by different values of S rather than R. These equalities are not testable
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because of the necessity of stratifying on S and thus requiring that the randomization
assumption for R hold for sub-groups defined by S, which is unfeasible under the
current set of assumptions. Hence, these interactions that are assumed to be zero
on the log scales are not identifiable without further assumptions.
For the second set of no-interaction assumptions, the main causal effects of R and
S are assumed not to vary between different groups distinguished by the levels of
the elements of X . We can theoretically stratify the sample by X and estimate the
above interaction and then test if the causal main effects of R and S are statistically
different across these strata, if of course there are sufficient subjects. Moreover,
one can code the specific variable elements of X such that the causal effects are
interpreted as a weighted average across the levels of these variable elements (e.g.,
Bond et al., 2007).

3.4

IV approaches

Since tumor response is a post-randomization variable, a major complication in
parameter estimation is that the standard regression estimator is inconsistent because of the existence of unmeasured confounders. A common strategy for dealing
with this problem is to use the IV approaches, which were originally implemented
by economists assuming exclusion restriction and are being increasingly applied in
medical studies. To adjust for confounding, it is important to obtain appropriate instruments for the IV approaches. In addition, the number of instruments should not
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be less than the number of estimated parameters in order to achieve identifiability.
A valid instrument must satisfy the following conditions: 1) it is correlated with the
tumor response; 2) it is uncorrelated with unmeasured confounders. The correlation
between the instrument and tumor response should be strong. Otherwise, an IV
approach with weak instruments is likely to produce estimates with large standard
errors even when the sample size is large. Another problem of weak instruments is
that the IV estimator is biased when sample size is small (Martens et. al., 2006;
Bound et. al., 1995). For randomized clinical trials, common candidate instruments
are the randomization variable and its interaction with baseline covariates that are
strong predictors of tumor response. For observational studies, it is more difficult
to identify a valid instrument. Many researchers have made recommendations for
identifying valid instruments and dealing with the problem of weak instruments for
observational studies (Martens et. al., 2006; Murray, 2006).
The IV 2SPS and 2SRI approaches are widely used to analyze continuous outcome
data because the estimators are asymptotically consistent even in the presence of
unmeasured confounding. There is an increasing use of these approaches to analyze
count data without formal justification. It is our interest to investigate whether or
not the IV estimators are consistent under log-linear SNMM. Both approaches are
two-stage regression models and have the same first-stage procedure. In the first
stage, we regress tumor response on instruments using logistic regression to obtain
the predicted value of tumor response. In the second-stage regression of the 2SPS
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X , R). In
approach, the tumor response S is replaced by its predicted value Ê(S|X
X , R) as an additional
contrast, the 2SRI approach includes the residual S − Ê(S|X
regressor in the model instead of replacing S in the second-stage estimation. In the
following sections, we will investigate the validity of using the two IV approaches
under log-linear SNMM with and without exclusion restriction in the presence of
unmeasured confounding.

3.5

Mediation analysis

In this section, we introduce the log-linear SNMM for mediation analysis under
confounding of the mediator-outcome relationship without the exclusion restriction.
We present the analytical bias of standard log-linear regression and the 2SPS and
2SRI approaches in estimating the causal parameters under this model.

3.5.1

Log-linear SNMM for mediation analysis

The causal contrasts of interest in mediation analysis are the direct effect of
X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = r)} and the
treatment log{E(Y (r,0) |X
X = x, R =
intermediate effect of the mediator (e.g., tumor response) log{E(Y (r,s) |X
X = x , R = r, S = s)} given that the treatment has been
r, S = s)} − log{E(Y (r,0) |X
assigned. These causal effects are related to the observed mean outcome on the log
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scale in the following log-linear SNMM

X = x, R = r, S = s)} = log{E(Y (0,0) |X
X = x)}
log{E(Y (r,s) |X


X = x , R = 0)} − log{E(Y (0,0) |X
X = x )}
+ log{E(Y (0,0) |X


X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = 0)}
+ log{E(Y (0,0) |X


X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = r)}
+ log{E(Y (r,0) |X


X = x , R = r, S = 0)} − log{E(Y (r,0) |X
X = x , R = r)}
+ log{E(Y (r,0) |X


X = x , R = r, S = s)} − log{E(Y (r,0) |X
X = x , R = r, S = 0)}
+ log{E(Y (r,0) |X


X = x , R = r, S = s)} − log{E(Y (r,0) |X
X = x , R = r, S = s)}
+ log{E(Y (r,s) |X
X = x )} + Γ1 (x
x) + q1 (x
x, r) + γ1 (x
x, r)
= log{E(Y (0,0) |X
x, r) + q2 (x
x, r, s) + γ2 (x
x, r, s)
+Γ2 (x

(3.5.1)
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where

x) = log{E(Y (0,0) |X
X = x, R = 0)} − log{E(Y (0,0) |X
X = x)}
Γ1 (x
x, r) = log{E(Y (0,0) |X
X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = 0)}
q1 (x
x, r) = log{E(Y (r,0) |X
X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = r)}
γ1 (x
x, r) = log{E(Y (r,0) |X
X = x , R = r, S = 0)} − log{E(Y (r,0) |X
X = x , R = r)}
Γ2 (x
x, r, s) = log{E(Y (r,0) |X
X = x , R = r, S = s)}
q2 (x
X = x , R = r, S = 0)}
−log{E(Y (r,0) |X
x, r, s) = log{E(Y (r,s) |X
X = x , R = r, S = s)}
γ2 (x
X = x , R = r, S = s)}
−log{E(Y (r,0) |X

The observed outcome on the log scale for subjects with assignment r and mediX = x )} plus
ator s can be estimated with baseline potential outcomes log{E(Y (0,0) |X
x) is the bias parameter reflecting
a series of effects related to R and S, where Γ1 (x
x, r) is the
the how the control group is different from the overall population; q1 (x
x, r) is the causal direct effect of R; Γ2 (x
x, r) is the effect of R,
selection bias; γ1 (x
x, r, s) is the unmeasured confounding
adjusting for S versus not adjusting for S; q2 (x
x, r, s) is the causal effect of S fixing R at any
correlated with mediator S; and γ2 (x
x, r) and γ2 (x
x, r, s) are Robins’ blip functions (Robins,
level r. The functions γ1 (x
1994, 2008) that define causal parameters for treatment and mediator given past
x), q1 (x
x, r), Γ2 (x
x, r), and q2 (x
x, r, s) are nuisance pahistory, and the functions Γ1 (x
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rameters that do not carry causal meanings. It directly follows from the model that
γ1 (x, 0) = γ2 (x, r, 0) = 0. Since the mediator is a post-randomization variable, it
does not play a role in the causal contrast when estimating the effect of treatment.
The SNMM model is nested since only variables that occur prior to the current
variable of interest are conditioned in causal contrasts.
x, r) as θR r and γ2 (x
x, r, s) as θS s in the following discusWe will parameterize γ1 (x
sions. Again, θR represents the direct effect of randomized treatment on outcome;
and θS represents the effect of mediator on outcome holding randomized treatment
x) = q1 (x
x, r) = 0. By
fixed at any level r. Under the randomization assumption, Γ1 (x
X = x , R = r, S = s)} = log{E(Y |X
X = x , R = r, S = s)}. AcSUTVA, log{E(Y (r,s) |X
x, R) and q2 (x
x, R, S) under log-linear SNMM (Robins
cording to the definition of Γ2 (x
et. al., 1999),

x, R) = −log[Es {exp(q2 (x
x, R, S))|X
X = x , R}].
Γ2 (x

X = x , R, S)} = δ X x + δR R + δS S
Assuming log-linear main effects, let log{E(Y (r,0) |X
x, R, S) can be expressed as
for all r. The function q2 (x

x, R, S) = log{E(Y (r,0) |X
X = x, R, S)} − log{E(Y (r,0) |X
X = x, R, S = 0)} = δS S
q2 (x
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and the explicit expression

x, R) + q2 (x
x, R, S) = q2 (x
x, R, S) − log[Es {exp(q2 (x
x, R, S))|X
X = x, R}]
Γ2 (x
= δS S − log{1 − p + p exp(δS )}

X = x , R). Assuming SUTVA and randomization of treatment
where p = E(S|X
assignment, the log-linear SNMM in equation (3.5.1) can therefore be simplified in
the following way

X = x , R, S)}
log{E(Y |X
X = x )} + θR R + (θS + δS )S − log{1 − p + p exp(δS )}(3.5.2)
= log{E(Y (0,0) |X

3.5.2

Estimation in the presence of unmeasured confounding

x, R) + q2 (x
x, R, S) in log-linear SNMM is a function of S, which may
The Γ2 (x
confound the the relationship between S and Y , and therefore is considered as the
effect of unmeasured confounders. Our goal is to investigate whether the estimators
resulting from the standard log-linear regression, 2SPS and 2SRI approaches are
consistent in the presence of unmeasured confounders. As we have seen for the
x, R)+q2 (x
x, R, S) can be expressed as the residual
linear SNMM, the confounding Γ2 (x
δS (S − p). The linear 2SRI model is the same as the linear SNMM and therefore the
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resulting estimators are unbiased. For the log-linear SNMM, however, by rewriting
equation (3.5.2) in the following way

X = x , R, S)} = log{E(Y (0,0) |X
X = x )} + θR R + θS S + δS (S − p)
log{E(Y |X
+δS p − log{1 − p + p exp(δS )}

(3.5.3)

and comparing it with the 2SRI model

X = x , R, S)} = log{E(Y (0,0) |X
X = x )} + θR R + θS S + δS (S − p),
log{E(Y |X

we can see that the 2SRI approach does not adjust for the term v = δS p −log{1 −p +
p exp(δS )} in the log-linear SNMM. Since v is a function of R that is correlated with
S, it confounds the effects of both treatment and mediator. In special case where
x, R)+q2 (x
x, R, S) ≈
δS ≈ 0, the bias of the 2SRI estimators are negligible because Γ2 (x
δS (S − p). To see this, by the Taylor series expansion,

log{1 − p + p exp(δS )}
= log{1 − p + p(1 + δS +
≈ log{1 − p + p(1 + δS )}
= log(1 + pδS )
≈ pδS
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δS2
+ ...)}
2

x, R) + q2 (x
x, R, S) ≈ δS (S − p) or v ≈ 0.
for −1 < pδS ≤ 1. Thus, δS ≈ 0 implies Γ2 (x
The 2SRI estimators are biased unless the log-linear SNMM in equation (3.5.3) and
the 2SRI model are approximately the same when δS ≈ 0.
Next, consider the standard log-linear regression which takes the form

X = x , R, S)} = log{E(Y (0,0) |X
X = x )} + θR R + θS S.
log{E(Y |X

Comparing the standard log-linear regression model with the log-linear SNMM, it
x, R) + q2 (x
x, R, S) in equation (3.5.2). In
does not adjust for the confounder Γ2 (x
x, R) + q2 (x
x, R, S) = 0 and the standard log-linear
special case where δS = 0, Γ2 (x
x, R) + q2 (x
x, R, S) is
regression estimators are unbiased. However, when δS 6= 0, Γ2 (x
correlated with R and S and the estimators are biased using the standard log-linear
regression.
Finally, as we have seen for linear SNMM, the linear 2SPS model is obtained
by taking double expectation of linear SNMM over S conditional on (xx,R). However, such technique does not apply to log-linear SNMM. Specifically, taking double
expectation of equation (3.5.2) yields

E



X = x, R, S)
E(Y |X
X = x, R
|X
X = x)
E(Y (0,0) |X



x, R]
= exp[θR R − log{1 − p + p exp(δS )}]E[exp{(θS + δS )S}|x
= exp[θR R − log{1 − p + p exp(δS )}]{1 − p + p exp(θS + δS )}.
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Therefore,

X = x, R)} = log{E(Y (0,0) |X
X = x)} + θR R − log{1 − p + p exp(δS )}
log{E(Y |X
+ log{1 − p + p exp(θS + δS )}.

(3.5.4)

The resulting expression is very different from the 2SPS approach

X = x , R)} = log{E(Y (0,0) |X
X = x )} + θR R + θS p.
log{E(Y |X

From equation (3.5.4), it is important to note that θS is not in the bias equation
because it is not related to p as a coefficient. The 2SPS estimators are therefore
biased.

3.5.3

Simulation results

We conduct simulation studies to compare the performance of standard log-linear
regression, 2SPS and 2SRI approaches in estimating the causal parameters θR and
θS defined by the log-linear SNMM. For the IV approaches, the strength of instrument is an important factor for obtaining unbiased causal estimates. We choose the
randomized treatment R and its interaction with baseline covariates RX that are
highly correlated with S as instruments to estimate the causal parameters. From
the theoretical results, unmeasured confounding introduces bias and our goal is to
investigate the numerical properties of the three estimators in terms of bias, % bias
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and MSE when unmeasured confounding is present. To investigate the small versus
large sample properties of the IV estimators, the simulation is conducted using 358
and 1000 subjects, each with 5000 replications. The sample size N = 358 is the
size of the lung cancer data, and N = 1000 is chosen so that we can examine the
asymptotic properties of the IV estimators. The variables are simulated based on the
log-linear SNMM in equation (3.5.2) for mediation analysis at the following order
1. Generate a bernoulli randomized treatment R and a bernoulli baseline covariate
X with 0.5 and 0.7 probability of success, respectively.
2. Generate a bernoulli mediator S with success probability

X , R) = expit{β0 + βR R + βX X + βRX RX}.
E(S|X

The parameter vector β = (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7).
3. Let U = δS S − log{1 − p + p exp(δS )} denote the unmeasured confounding
where δS can be varied for different confounding strengths.
4. Generate a Poisson outcome Y with mean

X , R, S) = exp{θ0 + θX X + θR R + θS S + U}.
E(Y |X

The parameter vector θ = (θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).
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Given the simulated variables, we increase the confounding factor δS by 0.2 at a
time between 0 and 2 in the analyses using the standard log-linear regression, 2SPS
and 2SRI approaches. The results that compare bias, % bias and MSE for the three
estimators are displayed in Table 3.1 and Table 3.2 for N = 358 and N = 1000,
respectively. The corresponding bias and % bias plots are presented in Figure 3.1
and Figure 3.2. The biases for N = 358 are more extreme and fluctuate more than
the analogous results for N = 1000. Due to the greater variability, the MSE for
N = 358 are larger, especially at the point δS = 1.4 where we observe an extremely
large MSE. The bias and % bias plots for N = 358 and N = 1000 both show similar
bias patterns, except at δS = 1.4 where the extreme value occurs. Therefore, the
results for the IV approaches using N = 1000 are more reliable, which will be the
focus in the following discussions.
For the most part, the numerical results are consistent with the theoretical results for the three methods. The log-linear regression estimators are unbiased when
there is no unmeasured confounding. The bias and % bias for log-linear regression
estimators increase linearly as the confounding factor δS increases. The 2SRI estimators are unbiased when confounding effect is small (δS < 0.8). The estimators
are biased for the 2SPS approach. In general, bias and % bias are smaller using
the 2SRI approach compared to the 2SPS approach, and are the worst using the
standard log-linear regression. We note that there is some difference between the
theoretical and simulated bias for the 2SPS approach when the mediator effect is
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small. For all the three methods, the mean square errors increase as the confounding
effect increases. When the effect of confounding is moderate to large (0.4 < δS < 2),
MSE is the biggest using the standard log-linear regression, followed by MSE using
the 2SPS approach, and MSE using the 2SRI approach is the smallest.

61

Table 3.1: Mediation analysis: A comparison of bias, % bias and MSE between
estimators using the standard log-linear regression, 2SPS and 2SRI approaches for
different confounding effects. The sample size is 358 using 5000 replications. The parameter vectors are β = (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), θ = (θ0 , θX , θR , θS ) =
(0.5, 0.7, −0.3, 1).

Loglinear

Bias
2SPS

2SRI

θR
θS

-0.00
-0.00

0.06
0.07

-0.01
0.02

θR
θS

-0.09
0.19

0.12
0.00

0.01
-0.04

θR
θS

-0.20
0.39

0.16
-0.02

0.01
-0.06

θR
θS

-0.31
0.59

0.21
-0.08

0.01
-0.10

θR
θS

-0.43
0.78

0.26
-0.14

0.00
-0.14

θR
θS

-0.55
0.98

0.29
-0.18

-0.02
-0.17

θR
θS

-0.68
1.17

0.35
-0.32

-0.03
-0.23

θR
θS

-0.81
1.37

0.21
0.04

-0.16
0.00

θR
θS

-0.94
1.57

0.42
-0.47

-0.10
-0.25

θR
θS

-1.07
1.77

0.46
-0.59

-0.12
-0.29

θR
θS

-1.21
1.97

0.47
-0.66

-0.19
-0.26

Loglinear

% Bias
2SPS

2SRI

Setting 1: δS = 0
0.05
20.36 3.33
0.01
6.73
1.95
Setting 2: δS = 0.2
31.54 40.99 4.41
19.41
0.39
3.88
Setting 3: δS = 0.4
66.06 52.90 2.86
39.02
1.56
5.61
Setting 4: δS = 0.6
103.29 70.71 3.65
58.84
8.15 10.44
Setting 5: δS = 0.8
142.70 85.24 0.27
78.42 14.43 14.49
Setting 6: δS = 1.0
182.39 95.29 6.89
97.64 18.37 16.51
Setting 7: δS = 1.2
225.37 116.59 10.21
117.50 32.02 23.02
Setting 8: δS = 1.4
269.07 68.64 54.89
137.27 3.62
0.16
Setting 9: δS = 1.6
312.86 139.55 33.56
156.90 47.12 24.78
Setting 10: δS = 1.8
358.27 153.83 40.92
176.79 58.82 29.29
Setting 11: δS = 2.0
402.46 155.26 62.37
196.52 65.77 25.58
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MSE
2SPS

2SRI

0.01
0.01

0.35
1.38

0.31
1.24

0.01
0.04

0.12
0.51

0.10
0.44

0.05
0.16

0.13
0.50

0.09
0.44

0.10
0.35

0.23
0.89

0.16
0.76

0.19
0.62

0.42
1.69

0.22
1.08

0.31
0.96

0.32
1.19

0.17
0.85

0.46
1.39

0.21
6.54

0.67
4.07

Loglinear

0.66
1.89

154.01 49.21
848.19 270.77

0.89
2.47

0.89
3.87

0.30
1.47

1.16
3.13

1.26
5.63

1.33
6.50

1.46
3.87

2.46
13.39

0.71
4.05

2.0

0.5
0.0

0.5

1.0

1.0
0.5
−0.5

0.0

Bias of S effect

0.0
−0.5

Loglinear Reg
2SPS
2SRI
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2SRI
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Figure 3.1: Mediation analysis: A comparison of bias and % bias plots between
estimators using the log-linear regression, 2SPS and 2SRI approaches as the effect of unmeasured confounding varies. The sample size is 358 using 5000 replications. The parameter vectors are β = (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7),
θ = (θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).
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Table 3.2: Mediation analysis: A comparison of bias, % bias and MSE between
estimators using the standard log-linear regression, 2SPS and 2SRI approaches for
different confounding effects. The sample size is 1000 using 5000 replications. The
parameters are β = (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), θ = (θ0 , θX , θR , θS ) =
(0.5, 0.7, −0.3, 1).

Loglinear

Bias
2SPS

2SRI

θR
θS

-0.00
-0.00

0.07
0.05

-0.00
-0.00

θR
θS

-0.10
0.20

0.10
0.06

-0.01
-0.00

θR
θS

-0.20
0.39

0.14
0.02

-0.00
-0.03

θR
θS

-0.31
0.57

0.17
0.00

-0.02
-0.04

θR
θS

-0.43
0.78

0.21
-0.04

-0.03
-0.07

θR
θS

-0.55
0.98

0.24
-0.08

-0.06
-0.07

θR
θS

-0.68
1.18

0.26
-0.13

-0.09
-0.08

θR
θS

-0.81
1.37

0.30
-0.20

-0.12
-0.10

θR
θS

-0.94
1.57

0.30
-0.23

-0.17
-0.09

θR
θS

-1.07
1.77

0.31
-0.28

-0.22
-0.08

θR
θS

-1.21
1.97

0.32
-0.34

-0.27
-0.06

Loglinear

% Bias
2SPS

2SRI

Setting 1: δS = 0
0.07
23.03 0.02
0.08
5.02
0.07
Setting 2: δS = 0.2
32.30 32.74 1.72
19.63
5.51
0.02
Setting 3: δS = 0.4
66.34 47.96 0.45
39.22
1.89
3.14
Setting 4: δS = 0.6
103.02 57.77 5.44
58.62
0.28
4.22
Setting 5: δS = 0.8
142.25 70.11 10.49
78.32
4.31
6.65
Setting 6: δS = 1.0
182.84 79.06 19.89
97.85
7.63
7.24
Setting 7: δS = 1.2
225.33 88.31 30.38
117.55 12.66 8.29
Setting 8: δS = 1.4
269.02 98.59 40.46
137.30 19.66 10.42
Setting 9: δS = 1.6
313.07 101.10 55.86
156.95 22.89 9.29
Setting 10: δS = 1.8
358.24 103.38 72.72
176.70 27.77 7.72
Setting 11: δS = 2.0
403.27 106.74 88.60
196.62 34.18 6.48
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MSE
2SPS

2SRI

0.00
0.00

0.03
0.12

0.03
0.11

0.01
0.04

0.04
0.12

0.03
0.11

0.04
0.16

0.05
0.13

0.03
0.11

0.10
0.35

0.06
0.14

0.03
0.12

0.18
0.62

0.08
0.17

0.03
0.13

0.30
0.96

0.10
0.21

0.03
0.13

0.46
1.38

0.13
0.29

0.04
0.15

0.65
1.89

0.17
0.41

0.05
0.18

0.88
2.47

0.19
0.48

0.07
0.19

1.16
3.12

0.21
0.63

0.09
0.21

1.47
3.87

0.25
0.81

0.12
0.23

Loglinear

2.0
0.5

1.0

1.0

1.5
0.0

0.0

0.5

Bias of S effect

0.0
−0.5

Loglinear Reg
2SPS
2SRI

−1.0

Bias of R effect

Loglinear Reg
2SPS
2SRI

1.5

2.0

0.0

0.5

2.0
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Figure 3.2: Mediation analysis: A comparison of bias and % bias plots between
estimators using the log-linear regression, 2SPS and 2SRI approaches as the effect
of unmeasured confounding varies. The sample size is 1000 using 5000 replications.
The parameters are β = (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), θ = (θ0 , θX , θR , θS ) =
(0.5, 0.7, −0.3, 1).
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3.6

Analysis assuming exclusion restriction

When unmeasured confounding is present, we have investigated the validity of
using the standard log-linear regression, 2SPS and 2SRI approaches for estimation
in mediation analysis. We now turn our attention to the analysis assuming exclusion restriction. In this section, we first introduce the log-linear SNMM for analysis
assuming exclusion restriction. Second, we investigate the validity of using the three
approaches in estimating causal parameters defined by log-linear SNMM when unmeasured confounding exists. Finally, we conduct simulation studies to compare the
performance of the three approaches in terms of bias, % bias, and MSE. Theoretical
results are confirmed by simulations and the conclusions are drawn based on the
results.

3.6.1

Log-linear SNMM assuming exclusion restriction

The log-linear SNMM assuming exclusion restriction is similar to the one for
mediation analysis except that we replace Y (r,s) by Y (s) and there is no direct causal
effect of treatment (θR = 0). The effect of the mediator on the outcome is estimated
by the following causal contrast

X = x , R, S)} − log{E(Y (0) |X
X = x , R, S)}
log{E(Y |X

66

(3.6.1)

The log-linear SNMM relates the observed mean outcome on the log scale with the
causal effect defined by equation (3.6.1) in the following way

X = x , R = r, S = s)} = log{E(Y (0) |X
X = x )}
log{E(Y (s) |X


X = x , R = 0)} − log{E(Y (0) |X
X = x )}
+ log{E(Y (0) |X


X = x , R = r)} − log{E(Y (0) |X
X = x , R = 0)}
+ log{E(Y (0) |X


X = x , R = r, S = 0)} − log{E(Y (0) |X
X = x , R = r)}
+ log{E(Y (0) |X


X = x, R = r, S = s)} − log{E(Y (0) |X
X = x, R = r, S = 0)}
+ log{E(Y (0) |X


X = x, R = r, S = s)} − log{E(Y (0) |X
X = x, R = r, S = s)}
+ log{E(Y (s) |X
X = x )} + Γ1 (x
x) + q1 (x
x, r)
= log{E(Y (0) |X
x, r) + q2 (x
x, r, s) + γ2 (x
x, r, s)
+Γ2 (x
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where

x) = log{E(Y (0) |X
X = x, R = 0)} − log{E(Y (0) |X
X = x)}
Γ1 (x
x, r) = log{E(Y (0) |X
X = x , R = r)} − log{E(Y (0) |X
X = x , R = 0)}
q1 (x
x, r) = log{E(Y (0) |X
X = x , R = r, S = 0)} − log{E(Y (0) |X
X = x , R = r)}
Γ2 (x
x, r, s) = log{E(Y (0) |X
X = x , R = r, S = s)}
q2 (x
X = x , R = r, S = 0)}
−log{E(Y (0) |X
x, r, s) = log{E(Y (s) |X
X = x , R = r, S = s)}
γ2 (x
X = x , R = r, S = s)}
−log{E(Y (0) |X

x) = q1 (x
x, r) = 0. By SUTVA,
Under the randomization assumption, Γ1 (x

X = x , R = r, S = s)} = log{E(Y |X
X = x , R = r, S = s)}.
log{E(Y (s) |X

x, r, s) as θS s. Thus, the logWe parameterize the causal effect of the mediator γ2 (x
linear SNMM can be simplified to

X = x , R, S)} = log{E(Y (0) |X
X = x )}+θS S +Γ2 (x
x, R)+q2 (x
x, R, S) (3.6.2)
log{E(Y |X

x, R)+q2 (x
x, R, S) represents the effect of unmeasured confoundThe quantity Γ2 (x
x, R) and
ing due to the endogenous variable S. According to the definition of Γ2 (x
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x, R, S) under log-linear SNMM (Robins et. al., 1999),
q2 (x

x, R) + q2 (x
x, R, S) = q2 (x
x, R, S) − log[Es {exp(q2 (x
x, R, S))|X
X = x, R}]
Γ2 (x
= δS S − log{1 − p + p exp(δS )}

X = x , R). Substituting the explicit expression for confounding in
where p = E(S|X
equation (3.6.2), the log-linear SNMM takes the following form

X = x , R, S)}
log{E(Y |X
X = x )} + (θS + δS )S − log{1 − p + p exp(δS )}.
= log{E(Y (0) |X

3.6.2

(3.6.3)

Estimation in the presence of unmeasured confounding

To investigate the consistency of the 2SRI estimator, we rewrite the log-linear
SNMM in equation (3.6.3) as

X = x, R, S)} = log{E(Y (0) |X
X = x)} + θS S + δS (S − p) + δS p
log{E(Y |X
−log{1 − p + p exp(δS )} (3.6.4)
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and compare it with the 2SRI model

X = x, R, S)} = log{E(Y (0) |X
X = x)} + θS S + δS (S − p).
log{E(Y |X

The 2SRI model does not adjust for the term v = δS p − log{1 − p + p exp(δS )}
in the log-linear SNMM. Since v is a function of R that is correlated with S, it
is a confounder for S. The 2SRI estimator is biased because of the unmeasured
confounders. Note that when the confounding effect is small (i.e. δS ≈ 0), log{1 −
p + p exp(δS )} ≈ pδS for −1 < pδS ≤ 1. In this case, v ≈ 0 implies that the loglinear SNMM in equation (3.6.4) and the 2SRI model are approximately the same.
Therefore, the bias of the 2SRI estimator for θS is negligible when δS ≈ 0.
Next, consider the following standard log-linear regression

X = x , R, S)} = log{E(Y (0) |X
X = x )} + θS S.
log{E(Y |X

Comparing it with the log-linear SNMM in equation (3.6.3), the standard log-linear
x, R) + q2 (x
x, R, S). Since
regression model does not adjust for the confounder Γ2 (x
x, R) + q2 (x
x, R, S) is correlated with S, the standard log-linear regression esΓ2 (x
timator is biased. However, when δS = 0 implying that there is no unmeasured
x, R) + q2 (x
x, R, S) = 0), the standard log-linear regression has the
confounding (Γ2 (x
same expression as the log-linear SNMM and the estimator is unbiased.
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Finally, the 2SPS estimate is obtained from the following model

X = x, R)} = log{E(Y (0) |X
X = x)} + θS p.
log{E(Y |X

By taking double expectation of equation (3.6.3),

E



X = x , R, S)
E(Y |X
X = x, R
|X
X = x)
E(Y (0) |X



x, R]
= exp[−log{1 − p + p exp(δS )}]E[exp{(θS + δS )S}|x
= exp[−log{1 − p + p exp(δS )}]{1 − p + p exp(θS + δS )}.

The log-linear SNMM condition on only x and R is

X = x , R)} = log{E(Y (0) |X
X = x )} − log{1 − p + p exp(δS )}
log{E(Y |X
+ log{1 − p + p exp(θS + δS )},

(3.6.5)

and the expression is very different from the 2SPS model. In fact, θS is not even
related to p as a coefficient in the log-linear SNMM as it is in the 2SPS model. The
2SPS estimator is therefore biased.

3.6.3

Simulation results

In this simulation study, we compare the performance of standard log-linear regression, 2SPS and 2SRI approaches in estimating θS . The three estimators are
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evaluated under log-linear SNMM assuming exclusion restriction. It is shown theoretically that the estimators are biased in the presence of unmeasured confounding.
By varying the confounding factor δS , we investigate numerically how the bias, %
bias and MSE of the three estimators change accordingly. Similar to what we did
for mediation analysis, the simulations are conducted using 358 and 1000 subjects,
each with 5000 replications. For each subject, the variables are simulated based on
the log-linear SNMM in equation (3.6.3) assuming exclusion restriction:
1. Generate a bernoulli randomized treatment R and a bernoulli baseline covariate
X with 0.5 and 0.7 probability of success, respectively.
2. Generate a bernoulli mediator S with success probability

X , R) = expit{β0 + βR R + βX X}.
E(S|X

Since the performance of the IV approaches depends on the strength of instrument, the randomized treatment R should be highly correlated with S. The
parameter vector β = (β0 , βR , βX ) = (−0.5, 2, 1).
3. Let the unmeasured confounding U = δS S − log{1 − p + p exp(δS )} where δS
is the confounding factor that takes the values between 0 and 2, increment by
0.2 at a time.
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4. Generate a Poisson outcome Y with mean

X , R, S) = exp{θ0 + θX X + θS S + U}.
E(Y |X

The parameter vector θ = (θ0 , θX , θS ) = (0.3, −0.6, 1.6).
Given the simulated data, the analysis results for different values of δS are displayed
in Table 3.3 using N = 358 and Table 3.4 using N = 1000. The corresponding bias
and % bias plots are presented in Figure 3.3 and Figure 3.4. The bias and % bias are
similar between the two sample size, but the MSEs are slightly smaller for N = 1000
than those for N = 358. We will focus the results using N = 1000 to draw the
conclusions. The results from analysis assuming exclusion restriction are similar to
those from the mediation analysis. The log-linear regression estimator is unbiased
when no confounder is present and is biased otherwise. Its % bias and MSE are the
largest among the three estimators when confounding effect is large (δS > 1.4). The
2SRI estimator is unbiased when confounding effect is small (0 < δS < 0.4), and its
% bias and MSE are the smallest. The 2SPS estimator is biased whether or not the
unmeasured confounding is present.
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Table 3.3: Assuming exclusion restriction: A comparison of bias, % bias and MSE
between estimators using the standard log-linear regression, 2SPS and 2SRI approaches for different confounding effects. The sample size is 358 using 5000 replications. The parameter vectors are β = (β0 , βR , βX ) = (−0.5, 2, 1), θ = (θ0 , θX , θS ) =
(0.3, −0.6, 1.6).

δS

Loglinear

0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0

0.00
0.17
0.34
0.51
0.69
0.87
1.05
1.23
1.43
1.61
1.81

Bias
2SPS
-0.48
-0.61
-0.72
-0.83
-0.93
-1.03
-1.11
-1.18
-1.25
-1.29
-1.35

% Bias
2SRI Loglinear 2SPS

2SRI

Loglinear

0.01
0.01
0.03
0.07
0.12
0.19
0.27
0.37
0.48
0.61
0.75

0.53
0.80
1.84
4.12
7.62
11.63
16.86
23.15
29.87
37.95
46.62

0.01
0.04
0.13
0.28
0.50
0.78
1.13
1.55
2.07
2.63
3.31

0.29
10.82
21.49
32.14
43.42
54.55
65.70
77.18
89.14
100.69
112.94
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30.20
37.83
45.20
51.85
58.09
64.24
69.26
73.50
78.17
80.91
84.31

MSE
2SPS

2SRI

0.27
0.40
0.56
0.73
0.91
1.11
1.29
1.45
1.64
1.75
1.90

0.03
0.03
0.03
0.04
0.06
0.08
0.13
0.20
0.30
0.45
0.65

1.0
0.0
−1.0
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Figure 3.3: Assuming exclusion restriction: A comparison of bias and % bias
plots between estimators using the log-linear regression, 2SPS and 2SRI approaches
as the effect of unmeasured confounding varies. The sample size is 358 using
5000 replications. The parameter vectors are β = (β0 , βR , βX ) = (−0.5, 2, 1),
θ = (θ0 , θX , θS ) = (0.3, −0.6, 1.6).
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Table 3.4: Assuming exclusion restriction: A comparison of bias, % bias and MSE
between estimators using the standard log-linear regression, 2SPS and 2SRI approaches for different confounding effects. The sample size is 1000 using 5000 replications. The parameter vectors are β = (β0 , βR , βX ) = (−0.5, 2, 1), θ = (θ0 , θX , θS ) =
(0.3, −0.6, 1.6).

δS

Loglinear

0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0

0.00
0.17
0.34
0.51
0.69
0.87
1.05
1.23
1.41
1.60
1.79

Bias
2SPS
-0.49
-0.61
-0.72
-0.83
-0.93
-1.02
-1.11
-1.18
-1.24
-1.30
-1.35

% Bias
2SRI Loglinear 2SPS

2SRI

Loglinear

0.00
0.01
0.03
0.07
0.12
0.19
0.27
0.37
0.48
0.60
0.74

0.02
0.53
1.86
4.20
7.38
11.94
17.00
22.98
30.08
37.65
46.13

0.00
0.03
0.12
0.27
0.48
0.76
1.10
1.52
2.01
2.58
3.22

0.08
10.50
21.30
31.99
42.89
54.10
65.34
76.70
88.40
100.18
111.91
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30.74
37.94
45.27
51.85
58.16
63.56
69.07
73.74
77.70
81.41
84.13

MSE
2SPS

2SRI

0.25
0.38
0.54
0.70
0.88
1.05
1.24
1.41
1.57
1.72
1.84

0.01
0.01
0.01
0.02
0.03
0.05
0.09
0.16
0.25
0.39
0.58

1.0
0.0
−1.0

Bias for S effect

Loglinear Reg
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Figure 3.4: Assuming exclusion restriction: A comparison of bias and % bias
plots between estimators using the log-linear regression, 2SPS and 2SRI approaches
as the effect of unmeasured confounding varies. The sample size is 1000 using
5000 replications. The parameter vectors are β = (β0 , βR , βX ) = (−0.5, 2, 1),
θ = (θ0 , θX , θS ) = (0.3, −0.6, 1.6).
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3.7

Bias analysis

In this section, we derive the closed form expressions of bias resulting from the two
IV approaches under a log-linear SNMM and perform simulation studies to confirm
the analytical results. Since the SNMM for mediation analysis is more general, our
analyses are based on the log-linear mediation model and can be applied similarly
to the analyses assuming exclusion restriction.

3.7.1

Bias analysis for the IV 2SPS approach

By parameterizing log{E(Y (0,0) |X)} = θ0 + θX X, the log-linear SNMM in equation (3.5.4) can be written as

log{E(Y |X, R)} = θ0 + θX X + θR R − log{1 − p + p exp(δS )}
+ log{1 − p + p exp(θS + δS )},

where p = E(S|X, R) = P r(S = 1|X, R). For binary variables X and R, there are
four possible values of p:

p00 = E(S|X = 0, R = 0)
p01 = E(S|X = 0, R = 1)
p10 = E(S|X = 1, R = 0)
p11 = E(S|X = 1, R = 1).
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Therefore, the log-linear mediation SNMM takes the following forms for different
combinations of X and R

log{E(Y |X = 0, R = 0)}
= θ0 − log{1 − p00 + p00 exp(δS )} + log{1 − p00 + p00 exp(θS + δS )}.
log{E(Y |X = 0, R = 1)}
= θ0 + θR − log{1 − p01 + p01 exp(δS )} + log{1 − p01 + p01 exp(θS + δS )}.
log{E(Y |X = 1, R = 0)}
= θ0 + θX − log{1 − p10 + p10 exp(δS )} + log{1 − p10 + p10 exp(θS + δS )}.
log{E(Y |X = 1, R = 1)}
= θ0 + θX + θR − log{1 − p11 + p11 exp(δS )}
+ log{1 − p11 + p11 exp(θS + δS )}.
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Let

a00 = log{1 − p00 + p00 exp(δS )}
a01 = log{1 − p01 + p01 exp(δS )}
a10 = log{1 − p10 + p10 exp(δS )}
a11 = log{1 − p11 + p11 exp(δS )}
b00 = log{1 − p00 + p00 exp(θS + δS )}
b01 = log{1 − p01 + p01 exp(θS + δS )}
b10 = log{1 − p10 + p10 exp(θS + δS )}
b11 = log{1 − p11 + p11 exp(θS + δS )},

then

[log{E(Y |X = 1, R = 1)} − log{E(Y |X = 1, R = 0)}]
− [log{E(Y |X = 0, R = 1)} − log{E(Y |X = 0, R = 0)}]
= −a11 + b11 + a10 − b10 + a01 − b01 − a00 + b00 .

(3.7.1)

Now we would like to express the IV 2SPS estimators as a function of θR and θS
in log-linear SNMM. The IV 2SPS model is

log{E(Y |X, R)} = α0 + αX X + αR R + αS p

80

and takes the following forms for different combinations of X and R

log{E(Y |X = 0, R = 0)} = α0 + αS p00

(3.7.2)

log{E(Y |X = 0, R = 1)} = α0 + αR + αS p01

(3.7.3)

log{E(Y |X = 1, R = 0)} = α0 + αX + αS p10

(3.7.4)

log{E(Y |X = 1, R = 1)} = α0 + αX + αR + αS p11 .

(3.7.5)

After calculating the differences between equations (3.7.2) and (3.7.3), and between
equations (3.7.4) and (3.7.5), we get

log{E(Y |X = 0, R = 1)} − log{E(Y |X = 0, R = 0)}
= αR + αS (p01 − p00 )

(3.7.6)

log{E(Y |X = 1, R = 1)} − log{E(Y |X = 1, R = 0)}
= αR + αS (p11 − p10 ).

(3.7.7)

Taking the difference between equations (3.7.6) and (3.7.7) yields

[log{E(Y |X = 1, R = 1)} − log{E(Y |X = 1, R = 0)}]
− [log{E(Y |X = 0, R = 1)} − log{E(Y |X = 0, R = 0)}]
= αS (p11 − p10 − p01 + p00 ).

81

(3.7.8)

By plugging equation (3.7.1) in equation (3.7.8), the IV 2SPS estimator for the
mediator effect is

α̂S =

−â11 + b̂11 + â10 − b̂10 + â01 − b̂01 − â00 + b̂00
p̂11 − p̂10 − p̂01 + p̂00

From equation (3.7.7), the IV 2SPS estimator for the treatment effect is

α̂R = log{E(Y |X = 1, R = 1)} − log{E(Y |X = 1, R = 0)} − α̂S (p11 − p10 )
= θR − â11 + b̂11 + â10 − b̂10 − α̂S (p̂11 − p̂10 ).

The resulting bias expressions are

α̂S − θS =

−â11 + b̂11 + â10 − b̂10 + â01 − b̂01 − â00 + b̂00
− θS
p̂11 − p̂10 − p̂01 + p̂00

α̂R − θR = −â11 + b̂11 + â10 − b̂10 − α̂S (p̂11 − p̂10 ).

(3.7.9)
(3.7.10)

In special case where δS = 0 and θS ≈ 0, we have a00 = a01 = a10 = a11 = 0,
b00 ≈ p00 θS , b01 ≈ p01 θS , b10 ≈ p10 θS , and b11 ≈ p11 θS . The resulting biases of α̂R
and α̂S approximate to zero.
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3.7.2

Bias analysis for the IV 2SRI approach

For binary variables X, R, and S, the log-linear SNMM in equation (3.5.2) takes
the following forms

log{E(Y |X = 0, R = 0, S = 0)} = θ0 − log{1 − p00 + p00 exp(δS )}
log{E(Y |X = 0, R = 0, S = 1)} = θ0 + θS + δS − log{1 − p00 + p00 exp(δS )}
log{E(Y |X = 0, R = 1, S = 0)} = θ0 + θR − log{1 − p01 + p01 exp(δS )}
log{E(Y |X = 0, R = 1, S = 1)} = θ0 + θR + θS + δS
−log{1 − p01 + p01 exp(δS )}
log{E(Y |X = 1, R = 0, S = 0)} = θ0 + θX − log{1 − p10 + p10 exp(δS )}
log{E(Y |X = 1, R = 0, S = 1)} = θ0 + θX + θS + δS
−log{1 − p10 + p10 exp(δS )}
log{E(Y |X = 1, R = 1, S = 0)} = θ0 + θX + θR − log{1 − p11 + p11 exp(δS )}
log{E(Y |X = 1, R = 1, S = 1)} = θ0 + θX + θR + θS + δS
−log{1 − p11 + p11 exp(δS )}.

We want to express the IV 2SRI estimators as a function of θR and θS in log-linear
SNMM. The IV 2SRI model is

log{E(Y |X, R, S)} = η0 + ηX X + ηR R + ηS S + ηI (S − p)
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For different combinations of X, R, and S, we have

log{E(Y |X = 0, R = 0, S = 0)} = η0 − ηI p00

(3.7.11)

log{E(Y |X = 0, R = 0, S = 1)} = η0 + ηS + ηI (1 − p00 )

(3.7.12)

log{E(Y |X = 0, R = 1, S = 0)} = η0 + ηR − ηI p01

(3.7.13)

log{E(Y |X = 0, R = 1, S = 1)} = η0 + ηR + ηS + ηI (1 − p01 )

(3.7.14)

log{E(Y |X = 1, R = 0, S = 0)} = η0 + ηX − ηI p10

(3.7.15)

log{E(Y |X = 1, R = 0, S = 1)} = η0 + ηX + ηS + ηI (1 − p10 )

(3.7.16)

log{E(Y |X = 1, R = 1, S = 0)} = η0 + ηX + ηR − ηI p11

(3.7.17)

log{E(Y |X = 1, R = 1, S = 1)} = η0 + ηX + ηR + ηS + ηI (1 − p11 )(3.7.18)

Taking the differences between equations (3.7.11) and (3.7.12), equations (3.7.11)
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and (3.7.13), equations (3.7.11) and (3.7.15), equations (3.7.13) and (3.7.17) yield

log{E(Y |X = 0, R = 0, S = 1)} − log{E(Y |X = 0, R = 0, S = 0)}
= ηS + ηI

(3.7.19)

log{E(Y |X = 0, R = 1, S = 0)} − log{E(Y |X = 0, R = 0, S = 0)}
= ηR + ηI (p00 − p01 )

(3.7.20)

log{E(Y |X = 1, R = 0, S = 0)} − log{E(Y |X = 0, R = 0, S = 0)}
= ηX + ηI (p00 − p10 )

(3.7.21)

log{E(Y |X = 1, R = 1, S = 0)} − log{E(Y |X = 0, R = 1, S = 0)}
= ηX + ηI (p01 − p11 )

(3.7.22)

To obtain η̂R and η̂S , we first solve for η̂I by taking the difference between equations (3.7.21) and (3.7.22):

[log{E(Y |X = 1, R = 0, S = 0)} − log{E(Y |X = 0, R = 0, S = 0)}]
−[log{E(Y |X = 1, R = 1, S = 0)} − log{E(Y |X = 0, R = 1, S = 0)}]
= ηI (p11 − p10 − p01 + p00 )
⇒ η̂I =

â11 − â10 − â01 + â00
.
p̂11 − p̂10 − p̂01 + p̂00
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From equation (3.7.19), the IV 2SRI estimator of the mediator effect is

η̂S = log{E(Y |X = 0, R = 0, S = 1)}
−log{E(Y |X = 0, R = 0, S = 0)} − η̂I
= θS + δS − η̂I .

From equation (3.7.20), the IV 2SRI estimator of the treatment effect is

η̂R = log{E(Y |X = 0, R = 1, S = 0)}
−log{E(Y |X = 0, R = 0, S = 0)} − η̂I (p̂00 − p̂01 )
= â00 − â01 + θR − η̂I (p̂00 − p̂01 ).

The resulting bias expressions are

where η̂I =

η̂R − θR = â00 − â01 − η̂I (p̂00 − p̂01 )

(3.7.23)

η̂S − θS = δS − η̂I ,

(3.7.24)

â11 −â10 −â01 +â00
.
p̂11 −p̂10 −p̂01 +p̂00

In the special case when δS = 0, we have a00 = a01 =

a10 = a11 = 0 so that η̂I = 0. Thus, the biases of η̂R and η̂S are exactly zero.
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3.7.3

Simulation results

In this simulation study, we check if the analytical bias expressions obtained from
simulations agree with the bias we derived in (3.7.9), (3.7.10), (3.7.23), and (3.7.24)
for the IV 2SPS and IV 2SRI approaches. The data are generated using the same
algorithm and the same parameter values as we described in Section 5. From the
results of previous simulations, the larger sample size gives more reliable estimates
and we therefore simulate our data using 1000 subjects with 5000 replications. The
simulation results are displayed in Table 3.5. Since the bias becomes negligible for
the 2SPS approach when δS = 0 and θS ≈ 0, we also present the results in Table
3.6 for this special case by setting θS = 0.001. For these tables, the first column
displays the bias from simulations while the second column displays the analytical
bias derived from the models. The differences between column 1 and 2 are displayed
in column 3, and the difference ratios (calculated as the bias difference in column
3 divided by the analytical bias in column 2) are displayed in column 4. As we
can see in Table 3.5, the results are similar between the empirical bias and the
analytical bias when the confounding factor δS is small (0 < δS < 0.6). However, the
differences become larger as δS increases yielding a bias ratio of 25.99 for the 2SRI
bias difference of θS when δS = 2. The large value of the ratio is partly due to the
very small denominator, which is approximately zero for the analytical bias of θS .
Overall, the analytical bias of the two IV approaches are not very different from the
empirical bias from simulations. From the results of Table 3.6 when θS is changed to
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0.001, we observe small empirical bias for the 2SPS approach as we expect from the
analytical results. Again, there is not much difference between the analytical and
empirical bias values. Since the analytical bias expressions are approximately zero
for the 2SPS approach when θS = 0.001, the bias difference ratios become very large
given that the denominators are very small.
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Table 3.5: Bias analysis for the 2SPS and 2SRI approaches under a log-linear
SNMM. The sample size is 1000 with 5000 replications. The parameters are
(β0 , βR , βX , βRX ) =(-3, 2, -0.5, 1.7), (θ0 , θX , θR , θS ) =(0.5, 0.7, -0.3, 1).
Simulation Bias Closed-form Bias Bias Difference
2SPS
2SRI
2SPS
2SRI
2SPS
2SRI

θR
θS

0.07
0.05

-0.00
0.00

0.07
0.05

θR
θS

0.10
0.04

0.00
-0.01

0.10
0.05

θR
θS

0.14
0.03

-0.01
-0.02

0.13
0.04

θR
θS

0.17
0.00

-0.02
-0.04

0.17
0.02

θR
θS

0.21
-0.05

-0.03
-0.07

0.20
-0.02

θR
θS

0.24
-0.08

-0.06
-0.08

0.23
-0.06

θR
θS

0.27
-0.13

-0.09
-0.09

0.25
-0.10

θR
θS

0.29
-0.18

-0.12
-0.10

0.27
-0.14

θR
θS

0.31
-0.24

-0.17
-0.10

0.28
-0.18

θR
θS

0.32
-0.29

-0.21
-0.09

0.29
-0.23

θR
θS

0.32
-0.33

-0.26
-0.07

0.28
-0.26

Setting 1: δS = 0
0.00
-0.00
0.00
0.00
Setting 2: δS = 0.2
-0.00
0.00
-0.00
-0.01
Setting 3: δS = 0.4
-0.01
0.00
-0.01
-0.01
Setting 4: δS = 0.6
-0.02
0.01
-0.03
-0.02
Setting 5: δS = 0.8
-0.04
0.01
-0.04
-0.03
Setting 6: δS = 1.0
-0.07
0.01
-0.05
-0.03
Setting 7: δS = 1.2
-0.10
0.02
-0.06
-0.04
Setting 8: δS = 1.4
-0.14
0.02
-0.05
-0.05
Setting 9: δS = 1.6
-0.19
0.03
-0.04
-0.06
Setting 10: δS = 1.8
-0.24
0.03
-0.02
-0.06
Setting 11: δS = 2.0
-0.30
0.03
0.00
-0.07
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Bias Diff. Ratio
2SPS
2SRI

-0.00
0.00

0.01
0.05

N/A
N/A

0.00
-0.01

0.03
0.14

1.47
1.71

0.00
-0.01

0.03
0.22

0.39
0.58

0.01
-0.02

0.04
0.93

0.29
0.56

0.01
-0.03

0.05
1.20

0.26
0.69

0.01
-0.03

0.05
0.54

0.17
0.59

0.02
-0.04

0.06
0.38

0.15
0.64

0.02
-0.05

0.08
0.34

0.15
0.88

0.03
-0.06

0.09
0.31

0.13
1.28

0.03
-0.06

0.10
0.28

0.12
2.64

0.03
-0.07

0.12
0.27

0.11
25.99

Table 3.6: Bias analysis for the 2SPS and 2SRI approaches under a log-linear
SNMM. The sample size is 1000 with 5000 replications. The parameters are
(β0 , βR , βX , βRX ) =(-3, 2, -0.5, 1.7), (θ0 , θX , θR , θS )=(0.5, 0.7, -0.3, 0.001).
Estimated Bias Closed-form Bias Bias Difference
2SPS
2SRI
2SPS
2SRI
2SPS
2SRI

θR
θS

-0.00
0.01

-0.00
0.01

0.00
0.00

θR
θS

-0.00
-0.00

-0.00
-0.00

0.00
0.00

θR
θS

0.01
-0.02

-0.00
-0.03

0.00
0.00

θR
θS

0.01
-0.02

-0.01
-0.05

0.00
0.00

θR
θS

0.01
-0.02

-0.04
-0.06

0.00
0.00

θR
θS

0.01
-0.03

-0.06
-0.08

0.00
0.00

θR
θS

0.01
-0.03

-0.09
-0.09

0.00
0.00

θR
θS

0.02
-0.04

-0.13
-0.10

0.00
0.00

θR
θS

0.03
-0.07

-0.16
-0.11

0.00
0.00

θR
θS

0.02
-0.05

-0.22
-0.07

0.00
0.00

θR
θS

0.03
-0.07

-0.27
-0.06

0.00
0.00

Setting 1: δS = 0
0.00
-0.00
0.00
0.01
Setting 2: δS = 0.2
-0.00
-0.00
-0.00
-0.00
Setting 3: δS = 0.4
-0.01
0.01
-0.01
-0.02
Setting 4: δS = 0.6
-0.02
0.01
-0.03
-0.02
Setting 5: δS = 0.8
-0.04
0.01
-0.04
-0.02
Setting 6: δS = 1.0
-0.07
0.01
-0.05
-0.03
Setting 7: δS = 1.2
-0.10
0.01
-0.05
-0.03
Setting 8: δS = 1.4
-0.14
0.02
-0.05
-0.04
Setting 9: δS = 1.6
-0.19
0.03
-0.04
-0.07
Setting 10: δS = 1.8
-0.24
0.02
-0.02
-0.05
Setting 11: δS = 2.0
-0.30
0.03
0.01
-0.07
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Bias Diff. Ratio
2SPS
2SRI

-0.00
0.01

56831.72
60302.04

N/A
N/A

-0.00
-0.00

45.59
2.55

0.56
0.08

0.01
-0.02

124.26
272.56

0.64
1.18

0.01
-0.02

105.80
336.18

0.37
0.84

0.01
-0.02

54.31
255.79

0.14
0.38

0.01
-0.03

86.29
824.91

0.18
0.63

0.01
-0.03

73.63
4398.49

0.13
0.62

0.02
-0.04

81.46
1544.99

0.12
0.82

0.03
-0.07

122.62
904.57

0.16
1.77

0.02
-0.05

79.77
406.03

0.09
2.24

0.03
-0.07

113.46
422.68

0.11
10.03

3.8

Application to lung cancer data

We now illustrate the implementation of IV approaches using the lung cancer
data. At the beginning of the study, totally 414 eligible subjects are recruited and
randomly assigned to take either the combined treatment of cisplatin and vinorelbine
or the single cisplatin treatment. The baseline covariate is patient’s performance status denoted by Xs . We code Xs = 1 if performance status is restricted or no effect
and Xs = 0 if performance status is fully active. The outcome of interest is survival status (alive or dead) determined at the 8th month after treatment assignment.
Again, note that we are modeling the same causal parameters under the log-linear
SNMM for the individual outcomes with the log-linear SNMM for the counts for different covariate patterns defined by treatment, tumor response, and the performance
status.
After randomization, subjects are followed up and categorized as responders or
non-responders according to their tumor response status at the 60th day after treatment assignment. Only 358 subjects who are alive at the time of tumor assessment
(60 days after randomization) are included in the analysis. It is shown in the exploratory analysis that treatment assignment is not significantly associated with
performance status (p = 0.23) for those subjects. Therefore, we cannot reject the
possibility that the randomization assumption is valid. Furthermore, for subjects
who are excluded from the analyses, there is no significant difference (p = 0.69) in
survival between the two treatment groups. We apply the standard log-linear re91

gression, 2SPS and 2SRI approaches to the lung cancer data to estimate the effects
of treatment and tumor response. The analysis are performed assuming 1) there
is a direct effect of treatment on the outcome asides from the effect of tumor response; and 2) the treatment affects outcome through the tumor response (exclusion
restriction).
In the first stage of the two IV methods, variables that are strong predictors
of tumor response should be selected as instruments. In addition, the number of
instruments should be equal or greater than the number of causal parameters in
order to have identifiable causal effects. Therefore, at least two instruments are
needed for mediation analysis. After performing a series of exploratory analyses, the
expected tumor response is obtained for both mediation analysis and the analysis
assuming exclusion restriction from the following model

h
i
ˆ R) = −1.95 − 0.84R − 0.08Xs + 1.76RXs ,
logit E(S|X,
where RXs is the interaction between randomized treatment and performance status.
While the effect of R is not significant (p = 0.20), the effect of RXs is significant
(p = 0.02) on the tumor response. We select both R and RXs as instruments for
the prediction of tumor response.
For the log-linear regression and the second stage of the IV methods, we regress
the outcome on R and S for mediation analysis and on S for analysis assuming
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exclusion restriction adjusting for Xs . The analysis results are displayed in Table
3.7. The estimates of θR and θS are quite different between the three methods for
analysis with and without assuming the exclusion restriction. The biggest difference
in estimates exists with the standard log-linear regression estimate of the tumor response effect adjusting for the randomized treatment factor and performance status.
In such case, there is a significant effect of tumor response (p = 0.01) and of opposite sign compared to the clearly non-significant IV estimates (p = 0.56 for the
2SPS method and p = 0.62 for the 2SRI method). For analysis assuming the exclusion restriction, the conclusions are similar to the mediation analysis except that
all the three approaches yield negative estimates of tumor response. For mediation
analysis, in contrast with the results for tumor response, all the three methods yield
non-significant treatment effects. Overall as we expected, the IV standard errors are
much larger than the standard log-linear regression standard errors, reflecting the
need for IVs that are more strongly related to tumor response.
Although the three approaches are biased for analyzing count data when unmeasured confounding of the tumor response-mortality relationship is present, we
compare the direct effect of randomized vinorelbine augmentation to the intent-totreat effect of vinorelbine. The intent-to-treat estimate of vinorelbine augmentation
not adjusting for tumor response is -0.19 (standard error = 0.15; p = 0.21). The
ITT estimate is similar to the log-linear regression estimate of -0.15 (standard error
= 0.15; p = 0.32) and not very different from the IV estimate of -0.26 (standard
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error = 0.19; p = 0.18) for the direct effect of treatment adjusting for the tumor
response. Consequently, there appears to be little mediation by tumor response for
the effect of vinorelbine augmentation on survival outcome. This is shown by the
lack of significance of tumor response on outcome under the IV approaches with
and without assuming exclusion restriction (but not under the log-linear regression
approach), suggesting that the effect may be indeed non-significant.
Overall, the log-linear regression and IV approaches lead to a mixed set of results
depending on which effect is being estimated. For the effect of tumor response on
outcome, the approaches dramatically differ. In contrast, for the effect of treatment,
the approaches lead to more similar results except in terms of the level of significance.
These differences could be due the presence of unmeasured confounding. Given we
cannot draw a valid conclusion based on the results, the purpose of this data analysis is to illustrate the implementation of the IV approaches rather than providing
recommendations for clinical decisions. In the situation in which the confounding
effect is believed to be small, the results from the 2SRI approach is more reliable
according to our simulation results.

3.9

Discussion

In this paper, we examine the validity of using the IV approaches in the context
of the log-linear SNMM to analyze count data with and without the exclusion restriction assumption. The mediation context was used for assessing departures from
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Table 3.7: Analysis results of the lung cancer trial using the standard log-linear
regression, 2SPS, and 2SRI approaches.

θS

θR
θS

Analysis assuming exclusion restriction
Log-linear Regression
2SPS
2SRI
Estimate Error
p
Estimate Error
p
Estimate Error
-0.69
0.27 0.01
-0.42
1.29 0.74
-0.57
1.30
Mediation analysis
Log-linear Regression
2SPS
2SRI
Estimate Error
p
Estimate Error
p
Estimate Error
-0.15
0.15 0.32
-0.26
0.19 0.18
-0.26
0.19
-0.67
0.27 0.01
0.96
1.66 0.56
0.81
1.66

p
0.66

p
0.18
0.62

the exclusion restriction. Our results show that the standard log-linear regression is
unbiased only if no unmeasured confounding is present. The IV 2SRI approach is
biased for moderate to large confounding and has negligible bias when confounding
effect is small. The IV 2SPS approach is biased whether or not the confounding is
present. This is also true for the logistic case (Cai et al., submitted manuscript). The
MSEs of the three estimators increase as the effect of confounding increases. When
the confounding effect is moderate to large, the standard regression method has the
largest MSE, followed by the 2SPS method, and the MSE of the 2SRI method is
the smallest. Therefore, the 2SRI approach is preferred when there is no or small
confounding. We should not use the 2SPS approach to estimate the treatment effect
for count data. Such results and recommendations are the same whether or not departures from the exclusion restriction is adjusted for. However, we saw the biggest
difference between estimates of the tumor response (mediator) when the exclusion
restriction was relaxed with the addition of a direct effect of randomized vinorelbine
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augmentation.
Since the mediator-outcome relationship is likely to be confounded by unmeasured factors, it becomes a challenge for investigators to obtain unbiased estimators using IV approaches under log-linear SNMMs. One possible solution is the
G-estimation approach, which is mostly applied assuming exclusion restriction and
sequential ignorability. Our future research will focus on relaxing these two assumptions for the G-estimation approach under log-linear SNMMs.
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Chapter 4
Mediation Analysis Using
G-estimation Approach Under a
Log-linear Structural Nested Mean
Model
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4.1

Introduction

In the context of mediation analyses of the mechanism of randomized interventions on a count outcome in randomized trials, we present a causal log-linear model
under which we make no assumptions regarding unmeasured confounding of the
mediator-outcome relationship. There has been much work on mediation analyses with the linear model (e.g., Robins, 2003; Pearl, 2001; Ten Have et al., 2007).
Vansteelandt (2009) proposed a log-linear structural nested mean model (SNMM)
estimated with sequential G-estimation for the mediation context in the presence
of an observed intermediate confounding variable. No unmeasured confounding for
both the randomized intervention and the mediator in terms of their effects on outcome (i.e., sequential ignorability) was assumed. The assumption of no unmeasured
confounding has been relaxed for causal log-linear models in the context of adjusting
for non-compliance (e.g., Johnston et al., 2008; Comté et al., 2009). However, these
approaches assumed no direct effect of the randomized intervention (i.e., exclusion
restriction), in contrast to the mediation problem where such an assumption is not
made because the direct effect is of primary interest.
Without the assumptions of sequential ignorability and exclusion restriction, we
present a set of weighted G-estimation equations that yield consistent and asymptotically normal estimators of the causal parameters defined by the mediation loglinear SNMM. Their variance attains the semi-parametric efficiency bound if optimal
weights are chosen (e.g., Joffe and Brensinger, 2003). While misspecification of the
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weight functions will only impact efficiency, but not consistency, they are important
in ensuring sufficient precision for estimation of the causal parameters without the
sequential ignorability and exclusion restriction assumptions. While the resulting
causal estimators are consistent, relaxation of the sequential ignorability and exclusion restriction assumptions leads to larger mean squared error than do competitive
estimators under either of these assumptions. For identifiability, we assume that
there is no interaction between the treatment and the mediator.
The motivation of our proposed log-linear mediation approach comes from a randomized clinical trial comparing mortality of advanced non-small-cell lung cancer
(NSCLC) patients randomized to vinorelbine augmentation of standard treatment
with cisplatin to those randomized to no augmentation of cisplatin (Wozniak et.
al., 1998). The mediation hypothesis is that augmentation with vinorelbine reduces
mortality by reducing tumor size. On the 60th follow-up day after assignment to
vinorelbine or no-vinorelbine, all randomized patients were measured for tumor response and categorized as responders or non-responders. Our analysis focuses on
assessing the direct effect of vinorelbine on outcome besides its effect through the
intermediate factor, tumor response.
In general, we are assuming that the outcome variable is a count variable for
a given individual, which justifies the choice of the log-linear model under which
parameters are interpreted in terms of risk ratios. However, for the lung cancer
data, the outcome at the individual level is binary (death or not). The specification
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of the log-linear model for the individual-level outcome leads to the log-linear model
with the same covariate effects for the sum of the individual-level outcomes across
subjects within each covariate pattern, which is a count variable.
We note that the G-estimation approach relies on asymptotic distributions and
the bias results in this paper only rely on first order moments, such that there are
no higher order distribution assumptions required for the outcome.
This paper is organized as follows. In section 2, we introduce notation on observed
and potential variables. We define causal effects of interest under a log-linear SNMM
for mediation analysis in section 3 and state the assumptions necessary to identify
and estimate causal parameters. In section 4, we present G-estimating equations for
unbiased estimation in randomized trial and outline the computational algorithm for
solving the estimating equations. Some formal proofs about the G-estimating equations are shown in Appendix. In section 5, by varying the magnitude of unmeasured
confounding, we compare the G-estimators with the standard log-linear regression
estimators via simulation studies. The methodology is illustrated in section 6 using
data from the lung cancer study. Finally, the paper concludes with a discussion of
the results and some future research directions.

4.2

Notation

In this section, we define observed and potential variables for subject i, i =
1, ..., n. All of the following variables apply to the ith of n patients and we suppress
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the index i to simplify notation. Let R = 1 if a patient is randomized to the
treatment (e.g., combined treatment of cisplatin and vinorelbine) and R = 0 if a
patient is randomized to the comparison group (e.g., a cisplatin only). For the lung
cancer data, we define a binary mediator although the approaches in this paper
accommodate continuous mediators. Let S = 1 if a patient exhibits level one of
the binary mediator (e.g., tumor response) and S = 0 if he/she exhibits level zero
(e.g., tumor non-response). For the discussion, we refer to the zero levels of R and
S as “reference” levels. The baseline covariates are denoted by X . Let Y be the
outcome variable. For the lung cancer data, Y is binary at the individual level
but the same causal parameters under the log-linear SNMM apply to the counts of
death among different covariate patterns defined by treatment, tumor response, and
baseline covariates. Our analyses are based on these counts.
To define the causal parameters and state the assumptions necessary to make
valid inference, we use the potential outcomes framework (Holland, 1986). It is assumed that each subject can be potentially exposable to any combination of the
randomized treatment levels (e.g., cisplatin and vinorelbine or cisplatin only) and
mediator levels (e.g., tumor response or non-response). Let Y (r,s) be the outcome
variable that would be observed if subject i were randomized to treatment r and
exhibits mediator level s. For binary treatment assignment and mediator, each subject has four potential outcomes: Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) . The reference potential
outcome Y (0,0) corresponds to the outcome that would be observed for the reference
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levels of R and S (e.g., no tumor response on the cisplatin only treatment arm). In
the next section, we will discuss the assumptions used to identify causal parameters.
The direct effect of treatment and mediation effect will be defined under a log-linear
SNMM.

4.3
4.3.1

Log-linear SNMM for mediation analysis
Assumptions

To identify the causal effects of interest in terms of potential outcomes under
the log-linear SNMM, we first introduce the corresponding assumptions necessary
for unbiased inference. The required assumptions are 1) the stable unit treatment
value assumption (SUTVA; Rubin, 1986; Angrist et al., 1996); 2) randomization of
treatment assignment; and 3) a number of no-interaction assumptions.
We consider the two components of SUTVA. First, the treatment assignment
and the level of mediator for one subject does not influence the outcomes of others.
That is, there is a single value for each of the potential random outcome variables
(Y (r,s) ) for a given patient i regardless of the randomization assignment or mediation
behavior of any other patient i′ . Notationally, we can denote the potential outcomes
for subject i as scalar indices Y (r,s) , rather than Y (rr ,ss) that takes n-dimensional vector indices of treatment and tumor response of all subjects into account. For our
example, it is likely that this part of SUTVA holds, unless an oncologist sees mul-
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tiple study patients and alters some aspect (e.g., dose) of the treatment in reaction
to the overall response (e.g., side effects) from the previous patients receiving the
treatment. Second, only one of the potential outcomes will be the observed outcome
for each subject even if the treatment assignment or tumor response occurrence
varies (“consistency”; Rubin, 1986). This assumption allows us to link the potential
outcomes to the observed outcome:

Y = rsY (1,1) + (1 − r)sY (0,1) + r(1 − s)Y (1,0) + (1 − r)(1 − s)Y (0,0) .

We propose the following specification of the randomization assumption for unbiasedness of the G-estimation estimating equations:

log{E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | R = r, X = x)}
= log{E(Y (1,1) , Y (1,0) , Y (0,1) , Y (0,0) | X = x)}.

Under this assumption, the first order moments of the potential outcomes and by
definition observed and unobserved baseline covariates should be equal between the
randomized intervention groups.
To achieve identifiability of the causal effects of R and S under the proposed
mediation SNMM, certain no-interaction assumptions are also needed (e.g., Ten Have
et al., 2007; Hernán and Robins, 2006). The first no-interaction assumption is that
there is no causal interaction on the log-scale between the randomized intervention
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and mediator. That is, there is no structural interaction term between R and S in
the proposed SNMM which would correspond to:

X = x , R = r, S = s)} − log{E(Y (1,0) |X
X = x , R = r, S = s)}
log{E(Y (1,1) |X
X = x , R = r, S = s)} − log{E(Y (0,0) |X
X = x , R = r, S = s)}
= log{E(Y (0,1) |X

for all r, s, and x . A topic of future research entails extending the weighted Gestimation approach for the current mediation model to the model augmented with
the corresponding causal interaction by adding another weighted estimating equation
for the interaction.
The second set of no-interaction assumptions requires that the causal main effects
of R and S must not differ across observed groups of subjects defined by the observed
levels of R and/or S. A representative no-interaction indicating no difference of the
causal main effect of R between two groups of subjects defined by R = 1 and R = 0
is presented as follows:

X = x , R = 1, S = s′ )} − log{E(Y (0,s) |X
X = x , R = 1, S = s′ )}
log{E(Y (1,s) |X
X = x , R = 0, S = s′ )} − log{E(Y (0,s) |X
X = x , R = 0, S = s′ )}
= log{E(Y (1,s) |X

for all x , s (which is the set indices of S), s′ (which is the observed value of S defining
the sub-group). Similar no-interaction equalities are needed when the sub-groups are
differentiated by different values of S rather than R. These equalities are not testable
104

because of the necessity of stratifying on S and thus requiring that the randomization
assumption for R hold for sub-groups defined by S, which is unfeasible under the
current set of assumptions. Hence, these interactions that are assumed to be zero
on the log scales are not identifiable without further assumptions.
For the second set of no-interaction assumptions, the main causal effects of R and
S are assumed not to vary between different groups distinguished by the levels of
the elements of X . We can theoretically stratify the sample by X and estimate the
above interaction and then test if the causal main effects of R and S are statistically
different across these strata, if of course there are sufficient subjects. Moreover,
one can code the specific variable elements of X such that the causal effects are
interpreted as a weighted average across the levels of these variable elements (e.g.,
Bond et al., 2007).

4.3.2

Model

We specify a model from the general class of multiplicative structural nested mean
log-linear models for longitudinal data (Robins et al., 1999; Vansteelandt, 2009). The
model is ”nested” in the sense that we only condition on information that is available
according to the current treatment history. For the proposed mediation analysis,
we only consider measurements at two time points. The treatment assignment is
measured at the first time point and the tumor response is measured at the second
time point. Since tumor response occurs after randomization, the effect of treatment
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under the log-linear SNMM is not conditional on tumor response, whereas the effect
of tumor response is conditional on treatment assignment. These casual effects are
parameterized in the following log-linear SNMM:

X = x , R = r, S = s)} = log{E(Y (0,0) |X
X = x )}
log{E(Y (r,s) |X


X = x , R = 0)} − log{E(Y (0,0) |X
X = x )}
+ log{E(Y (0,0) |X


X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = 0)}
+ log{E(Y (0,0) |X


X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = r)}
+ log{E(Y (r,0) |X


X = x , R = r, S = 0)} − log{E(Y (r,0) |X
X = x , R = r)}
+ log{E(Y (r,0) |X


X = x , R = r, S = s)} − log{E(Y (r,0) |X
X = x , R = r, S = 0)}
+ log{E(Y (r,0) |X


X = x , R = r, S = s)} − log{E(Y (r,0) |X
X = x , R = r, S = s)}
+ log{E(Y (r,s) |X
X = x )} + Γ1 (x
x) + q1 (x
x, r) + γ1 (x
x, r)
= log{E(Y (0,0) |X
x, r) + q2 (x
x, r, s) + γ2 (x
x, r, s)
+Γ2 (x

(4.3.1)
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where

x) = log{E(Y (0,0) |X
X = x, R = 0)} − log{E(Y (0,0) |X
X = x)}
Γ1 (x
x, r) = log{E(Y (0,0) |X
X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = 0)}
q1 (x
x, r) = log{E(Y (r,0) |X
X = x , R = r)} − log{E(Y (0,0) |X
X = x , R = r)}
γ1 (x
x, r) = log{E(Y (r,0) |X
X = x , R = r, S = 0)} − log{E(Y (r,0) |X
X = x , R = r)}
Γ2 (x
x, r, s) = log{E(Y (r,0) |X
X = x , R = r, S = s)}
q2 (x
X = x , R = r, S = 0)}
−log{E(Y (r,0) |X
x, r, s) = log{E(Y (r,s) |X
X = x , R = r, S = s)}
γ2 (x
X = x , R = r, S = s)}
−log{E(Y (r,0) |X

The log-linear SNMM expresses the log observable mean outcome in the subset
of population defined by baseline covariates, treatment assignment r and mediator
level s as the log expected baseline potential outcome plus a series of effects rex) is the bias parameter reflecting the
lated to treatment and mediator, where Γ1 (x
x, r) is the efhow the control group is different from the overall population; Γ2 (x
x, r)
fect of treatment, adjusting for mediator versus not adjusting for mediator; q1 (x
x, r, s) are functions that represent selection bias and unmeasured confoundand q2 (x
x, r) represents the direct causal effect of treatment on the outcome; and
ing; γ1 (x
x, r, s) represents the causal effect of mediator on the outcome holding treatment
γ2 (x
x, 0) = γ2 (x
x, r, 0) = 0.
fixed at any level r. It directly follows from the model that γ1 (x
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x), q1 (x
x, r), Γ2 (x
x, r), and q2 (x
x, r, s) carry non-causal information
The functions Γ1 (x
about the associations between treatment/mediator and the outcome. The functions
x, r) and γ2 (x
x, r, s), known as Robins’ blip functions (Robins, 1994), define the
γ1 (x
causal parameters of interest. We therefore parameterize the causal effects of treatment and mediator as θR and θS , respectively. The direct causal effect of treatment
denoted by θR is expressed as

.
X = x, R = r)} − log{E(Y (0,0) |X
X = x, R = r)}
θR r = log{E(Y (r,0) |X

(4.3.2)

and the causal effect of mediator denoted by θS is expressed as

.
X = x , R = r, S = s)}
θS s = log{E(Y (r,s) |X
X = x , R = r, S = s)}.
− log{E(Y (r,0) |X

(4.3.3)

Both exp(θR ) and exp(θS ) are interpreted as causal risk ratios. The risk of death for
subjects who have the treatment assignment set to r = 1 (e.g., cisplatin augmented
with vinorelbine) would be exp(θR ) times greater than if their treatment assignment
were set to r = 0 (e.g., cisplatin alone), given that the mediator is set to s = 0 (e.g.,
non-responder). For either value of r under the no R − S interaction assumption,
the risk of death for subjects who have the mediator set to s = 1 (e.g., responder)
would be exp(θS ) times greater than if their mediator were set to s = 0 instead.
The SNMM can be further simplified by the model assumptions we have discussed
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previously. The SUTVA consistency assumption relates the potential outcomes to
X = x, R = r, S = s)} = log{E(Y |X
X=
the observed outcome, resulting log{E(Y (r,s) |X
x) = q1 (x
x, r) = 0. The
x , R = r, S = s)}. By the randomization assumption, Γ1 (x
log-linear SNMM becomes

X = x , R = r, S = s)}
log{E(Y |X
X = x )} + θR r + θS s + Γ2 (x
x, r) + q2 (x
x, r, s).
= log{E(Y (0,0) |X

x, r)+q2 (x
x, r, s) involves unmeasured counterfactual
Note that the summation Γ2 (x
potential outcomes and is correlated with both treatment and tumor response, it is
therefore considered as the effect of unmeasured confounder. By the definition of
x, r) and q2 (x
x, r, s) under a log-linear SNMM (Robins et. al., 1999), we can
Γ2 (x
x, r) as a function of q2 (x
x, r, s) in the following way
express Γ2 (x

x, r) = −log[ES {exp(q2 (X
X , R, S))|X
X = x , R = r}].
Γ2 (x

X = x , R = r, S = s)} =
Assuming log-linear main effects, let log{E(Y (r,0) |X
x, r, s) takes the form
δ X x + δR r + δS s. The function q2 (x

x, r, s)
q2 (x
X = x , R = r, S = s)} − log{E(Y (r,0) |X
X = x , R = r, S = 0)}
= log{E(Y (r,0) |X
= δS s,
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x, r) + q2 (x
x, r, s) is
and the explicit expression of Γ2 (x

x, r) + q2 (x
x, r, s) = q2 (x
x, r, s) − log[ES {exp(q2 (X
X , R, S))|X
X = x, R = r}]
Γ2 (x
= δS s − log{1 − p + p exp(δS )},

X = x , R = r). Therefore, by SUTVA, the randomization assumpwhere p = E(S|X
x, r) and q2 (x
x, r, s), the log-linear SNMM in equation
tion, and the definitions of Γ2 (x
(4.3.1) can be written as

X = x , R = r, S = s)} = log{E(Y (0,0) |X
X = x )} + θR r + (θS + δS )s
log{E(Y |X
−log{1 − p + p exp(δS )}.

(4.3.4)

We will show in the next section that consistent estimators of θR and θS under
the log-linear SNMM in equation (4.3.4) can be obtained using the G-estimation
approach.

4.4

Estimation

In this section, we relax the sequential ignorability assumption and present a set
of weighted G-estimating equations, which take advantage of the randomized treatment assumption that allows unbiased parameter estimation even under unmeasured
confounding of the mediator-outcome relationship.
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4.4.1

G-estimation equations

For the G-estimation approach outlined below, the principal is to recover the
pretreatment potential outcomes for each subject by removing the causal effects
of treatment and mediator from their observed outcomes. The resulting predicted
baseline potential outcomes are uncorrelated with the randomized treatment variable, which is the key that leads to unbiased estimating equations. For subjects i,
the expected treatment-free, tumor response-free outcomes are defined as

H(θθ ) = Y exp(−θR R − θS S).

(4.4.1)

Specifically for subjects without tumor response on the standard treatment arm,
H(θθ ) is the observed outcome. Let θ = (θR , θS ), consistent estimators of θ can be
solved from the following estimating equation

J(θθ ) =

X
x)}W (x
x){H(θθ ) − b(x
x)} = 0,
{R − E(R|x

(4.4.2)

i

x) is a scalar and W (x
x) is a vector of two non-collinear components corwhere b(x
x) and b(x
x) are arbitrary functions
responding to weights for θR and θS . Both W (x
of baseline covariates. Consistency of the resulting G-estimators is not affected by
x) and b(x
x), but the asymptotic variance and semi-parametric efthe choices of W (x
ficiency of the estimators are impacted by specification of these functions (Robins,
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1994; Joffe and Brensinger, 2003). Under a structural distribution linear model and
sequential ignorability, Joffe and Brensinger (2003) showed that semi-parametric efx) = E(H(θθ )|x
x), which is the conditional expectation of
ficiency is achieved when b(x
x) is
treatment-free, tumor response-free outcomes given baseline covariates; and W (x
x) = [1 η(x
x)] where η(x
x) = E(S|R = 1, x ) − E(S|R = 0, x ). The first element in
W (x
x) is the weight for θR and the second element, known as the compliance score
W (x
x) measures the
(e.g., Follman, 2000), is the weight for θS . The compliance score η(x
effect of treatment on mediator conditional on baseline covariates. When estimating
the effect of mediator on the outcome, subjects characterized by x give more weights
x). To preclude collinearity with
in the estimation procedure if they have larger η(x
x), variation across X in the compliance score is needed. To
the weight for θR in W (x
determine the baseline covariates that satisfy this criterion, we test which variable
elements of X lead to strong interaction with R on S. Ten Have et al. (2007) used
this weight specification and selection approach under the linear rank preserving mediation model to obtain consistent estimators of the causal effects without sequential
ignorability. We also use this weight specification recognizing it is not optimal under
the log-linear SNMM. The simulation results in the next section show that the proposed choices of these functions work well for the G-estimation approach in terms
of confidence interval coverage.
We now proceed to show that the estimating equation (4.4.2) is unbiased. Equa-
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tion (4.3.2) can be equivalently written as

x, R = r} = E{Y (r,0) exp(−θR r)|x
x, R = r}.
E{Y (0,0) |x

(4.4.3)

X = x , R = r, S =
By the consistency assumption of SUTVA such that E(Y (r,s) |X
X = x , R = r, S = s)}, equation (4.3.3) is equivalent to
s)} = E(Y |X

x, R = r, S = s} = E{Y exp(−θS s)|x
x, R = r, S = s}.
E{Y (r,0) |x

(4.4.4)

Given equations (4.4.1), (4.4.3), and (4.4.4), it is shown in Theorem 1 that

x, R = r} = E{Y (0,0) |x
x, R = r}.
E{H(θθ )|x

(4.4.5)

Assuming randomization of treatment assignment, we have:

x, R} = E{Y (r,s) |x
x}.
E{Y (r,s) |x

(4.4.6)

x, R) = {R − E(R|x
x)}W (x
x), it follows that E{g(x
x, R)|x
x} = 0. It is shown
Letting g(x
in Theorem 2 that the weighted estimating equation (4.4.2) is unbiased under this
equality given equations (4.4.5) and (4.4.6). Consistent and asymptotically normal
estimators θ̂R and θ̂S can be obtained by iteratively solving the unbiased estimating
equation (4.4.2).
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4.4.2

Computational algorithm for parameter estimation

Since the estimating equation (4.4.2) is nonlinear in θR and θS , we cannot directly
derive closed form solutions from the estimating equations. We therefore solve the
unbiased estimating equations by an iterative Newton-Raphson algorithm. Let θ =
(θR , θS ), for a given θ̂θ

θ̂θ

(t)

(t+1)

at the tth iteration, the next θ̂θ

= θ̂θ

(t)

′

(t)

′

(t+1)

can be estimated by

(t)

− {Ĝ M(θ̂θ )}−1 Ĝ {H(θ̂θ ) − b̂}

x)}W (x
x), H(θθ ) ∈ Rn has ith element defined
where G ∈ Rn×2 has ith row {R − E(R|x
by equation (4.4.1), b ∈ Rn has ith element b(x), and M(θθ ) ∈ Rn×2 is the gradient
matrix of H(θθ ) with respect to θ with ith row equal to

∂H(θθ )
= −Y R exp(−θR R − θS S)
∂θR
∂H(θθ )
= −Y S exp(−θR R − θS S).
∂θS
(t)

′

At iteration t, Ĝ {H(θ̂θ ) − b̂} ∈ R2 is the estimated vector of J(θθ ) in equation
′

(t)

(4.4.2) and Ĝ M(θ̂θ ) ∈ R2×2 is the estimated matrix of

∂J(θθ )
∂θθ

(t)

evaluated at θ̂θ .

After convergence of the Newton-Raphson algorithm, the final estimate θ̂θ is ob′

tained. Let J(θθ ) = G {H(θθ ) − b}, it follows from the central limit theorem that
n1/2 (θ̂θ − θ ) is asymptotically normal with mean 0 and variance

V ar(θ̂θ ) = (Z −1 )D(Z −1)T
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′

where Z = G M(θθ ) and D =

P

i

J(θθ )J(θθ )T are both 2 × 2 matrices. The resulting

sandwich estimate V ˆar(θ̂θ ), where Ẑ and D̂ are evaluated at θ̂θ , is consistent even
when the model is misspecified. However, the price of robustness is loss of efficiency,
which results in larger variance of θ̂θ and wider confidence intervals. The asymptotic
standard errors will be used to calculate Wald statistics for hypothesis testing and
confidence intervals based on the consistent estimators of θR and θS .

4.5

Simulations

In this simulation study, we examine the numerical properties of the estimators
θ̂R and θ̂S obtained from the log-linear regression and the G-estimation approach
when unmeasured confounding exists. To investigate the small versus large sample
properties of these estimators, the simulations are carried out for different sample
sizes and we vary the magnitudes of unmeasured confounding under each setting.
The results are compared in terms of bias, percent bias, MSE, and percent coverage (a
proportion of iterations which the 95% confidence intervals cover the true parameters
θR and θS ).

4.5.1

Data generation

For each subject i, the variables are simulated in the following order based on
the log-linear mediation SNMM in equation (4.3.4) with parameter values based on
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fitting the model to the lung cancer data:
1. Generate a bernoulli treatment R and a bernoulli baseline covariate X with
0.5 and 0.7 probability of success, respectively.
2. Generate a bernoulli tumor response S with success probability

X , R) = expit{β0 + βR R + βX X + βRX RX}
E(S|X

3. Let the unmeasured confounding U = δS S − log{1 − p + p exp(δS )} where δS
can be varied for different confounding strengths.
4. Generate a Poisson outcome Y with mean

X , R, S) = exp{θ0 + θX X + θR R + θS S + U}
E(Y |X

We compare the performance of the two estimation approaches with 358 and 1000
subjects. The sample size N = 358 is the size of the lung cancer data and N = 1000
is chosen in order to have enough observations for the estimation approaches to work
well. For each sample size, we simulate 5000 sets of data and vary δS between 0 and 2
(from no confounding to large confounding), increment by 0.2 at a time, to examine
how the strengths of confounding impact the causal estimators of θR and θS .
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4.5.2

Simulation results and discussions

Since the specified values of θR and θS are very different (given the estimates
from the lung cancer data are very different), we calculate percent bias to normalize
the differences in parameters. For log-linear regression, percent bias is presented as
the mean-based percent bias = ( θ̄−θ
) × 100. For the G-estimation approach, given
θ
the skewness in distribution for the mean-based percent bias, we instead present
(θ̂)−θ
the ”median-based” percent bias = ( median
) × 100. Tables 4.1 and 4.2 report
θ

bias, percent bias, and MSE of the estimators of θR and θS and percent coverage
of the corresponding nominal 95% confidence intervals under the two estimation
approaches for varying levels of unmeasured confounding (δS ) separately for N = 358
and N = 1000. The bias and percent bias plots are presented in Figures 4.1 and
4.2 corresponding to each of the table. It happens occasionally that the NewtonRaphson algorithm fails to converge due to singular matrix problems. Therefore, we
exclude the results from these replications and record the percentage of such failure
for each confounding level in Tables 4.1 and 4.2.
The simulation results in Table 4.1 for sample size N = 358 are somewhat worse
than the analogous results in Table 4.2 for N = 1000. We observe that the percentage
of non-convergence iterations increases as the magnitude of unmeasured confounding
increases. For sample size N = 358, this situation is more severe, as there are nearly
25% non-convergence failures when δS = 2. Due to the small sample size and high
non-convergence percentage, the G-estimators of θR and θS are somewhat biased and
117

with confidence intervals that either have overcoverage or undercoverage for some
values of δS .
For N = 1000, the results are more reliable due to smaller percentage of nonconvergence. The estimators from log-linear regression are unbiased when there is
no confounding. However, as expected, they become much more biased than the
G-estimators when the mediator-outcome relationship is confounded. The medianbased percent bias of the G-estimators are uniformly smaller than the mean-based
percent bias from the log-linear regression, and the differences in percent bias between the two approaches become larger when the values of δS are bigger. As shown
in Figure 4.2, the bias from the log-linear regression increase linearly and more
rapidly compared to the G-estimators as the confounding effects increase. For our
simulation setting, the percent bias of θ̂R tends to be larger than the percent bias
of θ̂S for both estimation approaches. In comparison with the G-estimators, the
MSE of log-linear regression is smaller with ignorable confounding effect. When the
confounding effect increases from moderate (δS = 0.4) to large, the G-estimators has
smaller MSE. The larger MSE from the log-linear regression is due to the increased
bias associated with unmeasured confounding. For log-linear regression, the coverage is closed to 95% when there is no confounding. However, the coverage decreases
dramatically to zero when confounding gets large (δS > 0.4). For the G-estimation
approach, the estimated variance results in wider confidence intervals and greater
coverage, which is due to the sandwich estimator that overestimates the standard
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errors of θ̂R and θ̂S . When confounding effect is large, the coverage decreases slightly
because of relatively higher non-convergence percentage from the Newton-Raphson
algorithm.
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Table 4.1: Sample size N = 358. Comparisons of θ̂R and θ̂S for bias, percent
bias, MSE and percent coverage between log-linear regression and G-estimation
approach as the strengths of unmeasured confounding vary. The parameters
(β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).
Bias
Log- G Estilinear mation

θR
θS

-0.00
0.00

θR
θS

-0.10
0.20

θR
θS

-0.20
0.39

θR
θS

-0.31
0.59

θR
θS

-0.43
0.78

θR
θS

-0.55
0.98

θR
θS

-0.68
1.18

θR
θS

-0.80
1.37

θR
θS

-0.94
1.57

θR
θS

-1.07
1.77

θR
θS

-1.21
1.96

% Bias
Log- G Estilinear mation

MSE
Log- G Estilinear mation

% Coverage
Log- G Estilinear mation

Setting 1: δS = 0 (3.70% non-convergence)
0.02
0.21
0.82
0.01
0.09
94.98
0.07
0.10
0.70
0.01
0.56
95.16
Setting 2: δS = 0.2 (3.02% non-convergence)
0.02
32.43
0.07
0.02
0.10
75.38
0.06
19.85
0.31
0.05
0.50
25.94
Setting 3: δS = 0.4 (3.68% non-convergence)
0.01
66.44
4.15
0.05
0.12
26.56
0.05
39.22
2.80
0.16
0.48
0.02
Setting 4: δS = 0.6 (4.74% non-convergence)
0.01
102.81
3.43
0.10
0.13
2.52
0.04
58.62
1.73
0.35
0.45
0.00
Setting 5: δS = 0.8 (6.74% non-convergence)
0.02
142.00
6.68
0.19
0.15
0.08
0.02
78.32
3.49
0.62
0.46
0.00
Setting 6: δS = 1.0 (9.88% non-convergence)
0.00
182.71 13.24
0.31
0.17
0.00
0.03
97.98
8.07
0.97
0.47
0.00
Setting 7: δS = 1.2 (13.22% non-convergence)
-0.02
225.43 24.19
0.46
0.19
0.00
0.05
117.57 11.31
1.39
0.50
0.00
Setting 8: δS = 1.4 (14.54% non-convergence)
-0.03
268.04 29.06
0.65
0.22
0.00
0.05
137.10 13.40
1.89
0.58
0.00
Setting 9: δS = 1.6 (17.96% non-convergence)
-0.05
313.43 36.53
0.89
0.24
0.00
0.08
157.11 16.19
2.47
0.62
0.00
Setting 10: δS = 1.8 (20.64% non-convergence)
-0.07
357.19 45.19
1.16
0.27
0.00
0.10
176.64 20.06
3.13
0.70
0.00
Setting 11: δS = 2.0 (23.58% non-convergence)
-0.13
401.87 60.85
1.46
0.29
0.00
0.17
196.32 27.39
3.86
0.76
0.00
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98.05
98.57
98.02
99.13
97.76
99.56
97.63
99.58
97.04
99.31
96.09
98.60
94.93
97.23
93.45
95.62
93.47
94.71
91.61
93.09
90.32
92.10

2.0

0.0

1.0
0.5

Bias for S effect
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Figure 4.1: Sample size N = 358. Plots comparing bias, percent bias of θ̂R
and θ̂S between log-linear regression and G-estimation approach as the strengths
of confounding vary. The parameters are (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7),
(θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).

121

Table 4.2: Sample size N = 1000. Comparisons of θ̂R and θ̂S in terms of bias, percent bias, MSE and percent coverage between log-linear regression and G-estimation
approach as the strengths of confounding vary. The parameters (β0 , βR , βX , βRX ) =
(−3, 2, −0.5, 1.7), (θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).
Bias
Log- G Estilinear mation

θR
θS

-0.00
0.00

θR
θS

-0.10
0.20

θR
θS

-0.20
0.39

θR
θS

-0.31
0.59

θR
θS

-0.43
0.78

θR
θS

-0.55
0.98

θR
θS

-0.68
1.18

θR
θS

-0.81
1.37

θR
θS

-0.94
1.57

θR
θS

-1.07
1.77

θR
θS

-1.21
1.97

% Bias
Log- G Estilinear mation

MSE
Log- G Estilinear mation

% Coverage
Log- G Estilinear mation

Setting 1: δS = 0 (0.02% non-convergence)
0.00
0.12
0.07
0.00
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Figure 4.2: Sample size N = 1000. Plots comparing bias, percent bias of θ̂R
and θ̂S between log-linear regression and G-estimation approach as the strengths
of confounding vary. The parameters are (β0 , βR , βX , βRX ) = (−3, 2, −0.5, 1.7),
(θ0 , θX , θR , θS ) = (0.5, 0.7, −0.3, 1).
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4.6

Data analysis

In the lung cancer trial, 414 subjects were randomly assigned to take either the
combined treatment of cisplatin and vinorelbine or the single cisplatin treatment.
The outcome of interest is patient’s survival status (alive or dead) determined at the
15th month after treatment assignment. Again, note that we are modeling the same
causal parameters under the log-linear SNMM for the individual outcomes with the
log-linear SNMM for the counts for different covariate patterns defined by treatment,
tumor response, and baseline covariates.
For this analysis, patients were excluded if they died before the 60th day after
randomization because the tumor response measure at this time was needed for
the mediation analysis. Consequently, the randomization assumption for treatment
assignment may be questionable. However, we did not find any statistically imbalances between the randomization groups with respect to baseline covariates for the
resulting 358 subjects who were alive for tumor response assessment at the 60th postrandomization day. Furthermore, for subjects who are excluded from the analyses,
there is no significant difference (p = 0.69) in survival between the two treatment
groups. Among the 358 analyzed subjects, 281 subjects died between the 60th day
and the 15th month after randomization. There are 73.6 % of deaths for subjects
treated with both cisplatin and vinorelbine and 83.5 % of deaths for subjects treated
with only cisplatin. For subjects who have tumor response, the proportion of death
is 0.66 if they receive both medicines and is 0.57 if they only receive cisplatin treat124

ment. In comparison, for subjects with no tumor response, the proportion of death
is 0.75 if they are treated with both medicines and is 0.87 if they are only treated
with cisplatin.
We now present a comparison between the standard log-linear regression and the
G-estimation approach for analysis of the lung cancer data. For the G-estimation
approach, a compliance score (the effect of treatment on tumor response controlling
for baseline covariates) is needed for the weight of θS to improve the efficiency of
the estimators. We choose the baseline covariates that have strong interaction with
treatment on the mediator to preclude collinearity between the weights for θR and
θS . After a series of exploratory analyses using a logistic model, there is a significant
interaction (p = 0.02) between treatment and performance status on the tumor
response. Therefore, performance status is chosen from a set of baseline covariates to
compute the compliance score. For the log-linear regression approach, the following
model is used for mediation analysis

E(Y |R, S, XP ) = exp(θ0 + θR R + θS S + θP XP ),

where XP is the performance status variable, and we code XP = 1 if performance
status is restricted or no effect and XP = 0 if performance status is fully active.
The results obtained from both analyses are displayed in Table 4.3. The results
are quite different between the two approaches, indicating the potential presence of
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unmeasured confounding. For either approach, there is no significant causal effect
of tumor response on the log expected outcome. In comparison, the direct effect of
treatment is marginally significant (p = 0.05) under the G-estimation approach while
the effect is not significant from the standard log-linear regression analysis (p = 0.40).
The standard errors of θ̂R are similar between the two approaches, although the Gestimation approach results in a smaller standard error. In contrast, the standard
error of θ̂S is much larger under the G-estimation approach compared to that under
the log-linear regression. As we have shown both theoretically and numerically,
the estimators obtained from the G-estimation approach have less bias than the
standard log-linear regression approach regardless of the magnitude of unmeasured
confounding. The results from data analysis illustrate to some extent the trade-off
between precision and unbiasedness. Conclusions are drawn based on the results
from the G-estimation approach. Tumor response does not have a significant effect
on the log expected outcome. In contrast, holding tumor response constant, adding
vinorelbine to ciplatin significantly reduces the risk of death by approximately 16%
(1 − exp(−.18)).
To investigate whether adjusting for tumor response reduces the effect of vinorelbine augmentation thus suggesting at least partial mediation, the intent-totreat estimate of vinorelbine augmentation not adjusting for tumor response is -0.12
(standard error = 0.12; p = 0.32), which is very similar to the log-linear regression
estimate of -0.10 (standard error = 0.12; p = 0.40) for the direct effect of treatment
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adjusting for the tumor response. Using the G-estimation approach, however, the effect of vinorelbine augmentation adjusting for the tumor response is -0.18 (standard
error = 0.09; p = 0.049), which is marginally significant due to the smaller standard
error although there is not much difference in magnitude for parameter estimates.
There appears to be little mediation by tumor response for the effect of vinorelbine
augmentation on survival outcome. This is confirmed by the lack of significance of
tumor response on outcome under both the log-linear regression and G-estimation
approaches.
Overall, the log-linear regression and G-estimation approaches lead to a mixed set
of results depending on which effect is being estimated. For the effect of the potential mediator, tumor response, on outcome, both approaches lead to non-significant
results although the estimates are dramatically different. In contrast, for the effect
of the randomized treatment, vinorelbine augmentation, the two approaches lead to
more similar estimates except that the G-estimation approach yields a marginally
significant effect while the effect is not significant from the log-linear regression.
These differences between the two approaches could be due to the presence of unmeasured confounding of the tumor response-outcome relationship and/or due to
the presence of a causal interaction between the vinorelbine and tumor response on
outcome. A naive analysis of this interaction based on log-linear regression yields a
p-value of 0.53, and our future research will focus on assessing whether the causal
interaction is significant.
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Table 4.3: Mediation analysis: a comparison between the standard log-linear regression and G-estimation approach.

θR
θS

4.7

Log-linear Regression
Point St.
95%
Est. Err.
C.I.
p
-0.10 0.12 (-0.34, 0.13) 0.40
-0.28 0.19 (-0.64, 0.09) 0.14

Point
Est.
-0.18
1.10

G-estimation
St.
95%
Err.
C.I.
p
0.09 (-0.36, 0.00) 0.049
1.88 (-2.58, 4.79) 0.56

Discussion

We have proposed a new approach under the multiplicative or log-linear SNMM
to analyze the direct effect of randomized treatment in the presence of a postrandomization mediator for which we make no assumptions about measured or unmeasured confounding. This approach is based on a log-linear model extension of
a weighted test-based approach by Robins and Greenland (1994) for testing direct
treatment and mediator effects with respect to survival outcomes. The multi-element
weight vector with separate weights for each parameter leads to separate identifying equations for each parameter. The absence of perfect collinearity among the
weight elements ensures that the identifying equations achieve a full rank identifying matrix. We use the same weight functions that Ten Have et al. (2007) used for
the same purpose but under a log-linear model. Our simulations show that while
these weight functions are not optimal, they lead to good confidence intervals for our
proposed G-estimators under the log-linear SNMM with no assumptions regarding
confounders of the mediator-outcome relationship.
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In addition to the bias versus variability tradeoff shown in the simulations, the
weighted G-estimation approach exchanges the untestable sequential ignorability assumption for not fully testable no-interaction assumptions among baseline covariates,
treatment, and mediator. In our study, there was clinical conjecture about potential
unmeasured confounders that would violate the sequential ignorability assumption.
However, there is also clinical weight given to interactions between treatment and
mediator on the survival outcome. Balancing these assumptions is a clinical judgement. We are in the process of extending the proposed log-linear mediation SNMM
to include a structural interaction by adding another weighted G-estimation equation
to account for this interaction based on the criteria of Robins et al. (1992).
Our future research will also focus on determining baseline covariates satisfying
these conditions for the lung cancer data and other datasets. While the weights we
used yield consistent estimators under departures from sequential ignorability, they
are not semi-parametric efficient under these departures. Chamberlain (1992) has
shown how this can be done to attain the semi-parametric efficiency bound and will
be a topic for our future research.
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Appendices
Theorem 1. By equations (4.4.1), (4.4.3), and (4.4.4), the following equality holds

x, R = r} = E{Y (0,0) |x
x, R = r}.
E{H(θθ )|x

Proof.

x, R = 0)
E(H(θθ )|x
x, R = 0, S = 0)P r(S = 0|x
x, R = 0)
= E(H(θθ )|x
x, R = 0, S = 1)P r(S = 1|x
x, R = 0)
+E(H(θθ )|x
x, R = 0, S = 0)P r(S = 0|x
x, R = 0)
= E(Y |x
x, R = 0, S = 1)P r(S = 1|x
x, R = 0)
+E(Y exp(−θS )|x
x, R = 0, S = 0)P r(S = 0|x
x, R = 0)
= E(Y (0,0) |x
x, R = 0, S = 1)P r(S = 1|x
x, R = 0)
+E(Y (0,0) |x
x, R = 0)
= E(Y (0,0) |x

The second equality holds by the definition of H(θθ ) in equation (4.4.1) and the third
equality holds because of equation (4.4.4).
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Similarly,

x, R = 1)
E(H(θθ )|x
x, R = 1, S = 0)P r(S = 0|x
x, R = 1)
= E(H(θθ )|x
x, R = 1, S = 1)P r(S = 1|x
x, R = 1)
+E(H(θθ )|x
x, R = 1, S = 0)P r(S = 0|x
x, R = 1)
= E(Y exp(−θR )|x
x, R = 1, S = 1)P r(S = 1|x
x, R = 1)
+E(Y exp(−θR − θS )|x
x, R = 1, S = 0)P r(S = 0|x
x, R = 1)
= exp(−θR ){E(Y (1,0) |x
x, R = 1, S = 1)P r(S = 1|x
x, R = 1)}
+E(Y (1,0) |x
x, R = 1)
= E(Y (1,0) exp(−θR )|x
x, R = 1)
= E(Y (0,0) |x

The second equality holds by the definition of H(θθ ) in equation (4.4.1). The
third equality holds because of equation (4.4.4). The last equality holds by equax, R = r} =
tion (4.4.3). Given the above equalities, we have shown that E{H(θθ )|x
x, R = r}.
E{Y (0,0) |x
Theorem 2. By equations (4.4.5), and (4.4.6), the estimating equation (4.4.2) is
unbiased.
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Proof.

x, R)H(θθ )|x
x}
E{g(x
x, R)H(θθ )|x
x, R = 0}P r(R = 0|x
x)
= E{g(x
x, R)H(θθ )|x
x, R = 1}P r(R = 1|x
x)
+E{g(x
x, 0)E{Y (0,0) |x
x, R = 0}P r(R = 0|x
x)
= g(x
x, 1)E{Y (0,0) |x
x, R = 1}P r(R = 1|x
x)
+g(x
x}{g(x
x, 0)P r(R = 0|x
x) + g(x
x, 1)P r(R = 1|x
x)}
= E{Y (0,0) |x
x}E{g(x
x, R)|x
x} = 0.
= E{Y (0,0) |x

The second equality holds because of equation (4.4.5), the third equality holds
x, R)|x
x} = 0.
because of equation (4.4.6), and the last equality holds because E{g(x
x, R)H(θθ )|x
x} = 0, E{g(x
x, R)H(θθ )} = 0. The estimating equation (4.4.2)
Since E{g(x
is therefore unbiased.
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